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1. Introduction 
 
 
Chromosomal rearrangements, especially balanced chromosomal 
translocations, play a pivotal role in leukemogenesis. The best known 
example of the causal relationship between a chromosomal translocation 
and a malignancy is the Philadelphia chromosome and chronic myeloid 
leukemia (CML). The Philadelphia chromosome, which was identified in the 
early 1960ies, is the result of a balanced translocation of chromosomes 9 
and 22. This translocation results in the production of a fusion protein, the 
BCR/ABL fusion protein, which is directly responsible for the malignant 
transformation in CML. Today we know of more than 100 recurring 
chromosomal rearrangements that lead to the formation of fusion genes and 
fusion proteins (Mitelman, 1994). Balanced chromosomal translocations do 
not only lead to the formation of fusion genes but can also result in 
transcriptional deregulation of genes close to the breakpoints. This is, for 
example, the case in the t(8;14) translocation found in Burkitt’s lymphoma 
which leads to the overexpression of the MYC oncogene through 
juxtapposition of the immunoglobulin heavy chain enhancer / promoter. 
Chromosomal rearrangements affecting band 12p13 have been the focus of 
investigators since the early 1990ies. 12p rearrangements, both translocation 
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and deletions, can be found in a wide spectrum of hematopoietic 
malignancies (acute lymphoblastic leukemia (ALL), chronic myelomonocytic 
leukemia (CMMoL)) and also in certain solid tumors, like congenital 
fibrosarcome and secretory breast carcinoma. In 1994, Golub et al. identified 
the TEL gene (later called ETV6) on 12p13 as the fusion partner of the 
PDGFRβ(platelet derived growth factor) gene in cases with CMMoL and a 
t(5;12). Subsequently, ETV6 has been identified as the fusion partner of at 
least 17 other genes. While in most of these translocations fusion proteins 
are formed between ETV6 and the partner genes, deregulation of oncogenes 
seems also to play a role in a few translocation involving ETV6 (Rawat et al., 
2004). Deletions affecting 12p have a smallest region of overlap 
encompassing ETV6 (Sato et al., 1995). These and other data suggest that 
ETV6 might also function as a tumor suppressor gene. Because of its 
prominent function in malignant transformation in the hematopoietic system, 
studies trying to elucidate the function of ETV6 are the focus of this work. 
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1.1   ETV6 
 
1.1.1 The ets family of transcription factors 
 
ETV6 (ETS variant gene 6) was originally called TEL, for translocation ets 
leukemia gene. ETV6 is a member of the ets (erythroblast transformation 
specific) family of transcription factors. ets proteins all share a conserved 85 
amino acid long DNA binding domain called the ets domain. Some ets 
proteins also have another conserved domain: the SAM domain (also called 
pointed domain, helix-loop-helix domain). There are more than 40 members 
of this family, which have been found in species ranging from sponges, 
nematodes and insects to humans. ets domain proteins are involved in many 
cellular and organismal functions like proliferation, differentiation, 
development, transformation, and apoptosis. Most members of the ets family 
have been shown to be transcriptional activators except for three ets proteins, 
YAN, ERF and ETV6, which act as transcriptional repressors. There are also 
some members which function as activators or repressors depending on their 
interactions with specific cofactors and on the promoter context, such as 
ELK-1 (Janknecht et al., 1994; Yang et al., 2001), SAP-2/NET (Price et al., 
1995), NERF-1/-2 (Cho et al., 2004), and ESE-1/-2/-3. (Table 1.1, (Sharrocks, 
2001)). 
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Table 1.1 The ets domain protein family. Sharrocks, 2001  
 
The ets domain is not only a DNA binding domain but also an interface for 
protein-protein interaction. This ets domain binds a purine rich GGAA/T core 
DNA (Karim et al., 1990). The structure and biochemical studies show that 
Table 1.1 The ets domain proteins
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the ets domain has a winged helix-turn-helix structure (Donaldson et al., 
1996). In recent years, structural studies of ets domains complexed with DNA 
have show that also some non-conserved amino acid residues of the ets 
domain contribute to the protein-DNA interaction. These findings explain why 
different members of the ets family that have highly similar ets domain 
recognize different DNA sequences. (Mo et al., 2000; Obika et al., 2003). The 
ets domain has also been shown to function as an activator or repressor of 
transcription (Virbasius et al., 1993; Maurer et al., 2003; Graves et al., 1996). 
Protein-protein interactions may modify the DNA binding properties of the ets 
domains, which in turn may change the transcriptional regulation at specific 
promoters (Baert et al., 2002; Carrere et al., 1998). These interactions either 
positively or negatively influence DNA binding (Table.1.2) (Galanis et al., 
2001). 
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Table 1.2 The DNA binding partners of ets proteins. Sharrocks, 2001  
 
The pointed or SAM (Sterile alpha motif) domain is an evolutionarily 
conserved protein binding domain with 65 to 70 amino acids found in more 
Table 1.2  Binding partners for ETS-domain transcription factors 
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than 250 regulatory proteins including receptor tyrosine kinases and 
transcription factors (Kim et al., 2001; Kyba and Brock, 1998; Schultz et al., 
1997). This domain is involved in the regulation of numerous developmental 
processes in diverse eukaryotes. The pointed domain mediates 
protein-protein interaction to form homotypic or heterotypic oligomers with 
other pointed (or SAM) domains, which organize protein complexes in the 
cell (Barrera et al., 2002). Various members of the ets family such as Ets-1/-2, 
Fli-1, Erg, GABP, YAN, ETV7 and ETV6 have this domain (Jansen et al., 
2001; McGrath et al., 2001; Sharrocks, 2001). 
 
ets proteins are found in most multicellular organisms. They are involved in 
mammalian developmental processes at the cellular, tissue and organ level. 
Various studies show that ets proteins play important roles in hematopoiesis 
and vasculogenesis/angiogenesis, at the earliest stages of embryogenesis 
and later in tissue development. ets genes are expressed in hematopoietic 
cells, the vasculature, brain and central nervous system, mammary gland, 
endometrium, ovaries, testes, kidneys and lungs. Different members of the 
ets family have different functions in the regulation of cell proliferation, 
differentiation, migration, apoptosis and in cellular interactions (reviewed by 
(Sharrocks, 2001; Sementchenko and Watson, 2000)).  
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Extracellular signals from ligand-receptor interactions on the cell surface are 
conveyed through numerous cytoplasmic signaling pathways to the nucleus. 
The responses of the cell to these signals are temporary or permanent 
changes in gene expression resulting in cell proliferation, differentiation or 
survival. For examples, the mitogen-activated protein kinase (MAPK) 
pathway and calcium dependent kinases pathway play important roles in 
cellular signal transduction. Many ets family proteins have been shown to be 
the nuclear targets of such signaling pathways acting as downstream 
effectors, especially in MAPK pathway. ets proteins with pointed domains like 
Ets-1 and Ets-2 as well as YAN have a single MAPK phosphorylation site, 
which localizes near the pointed domain. On the other hand, TCF which does 
not have a pointed domain also has a phosphorylation domain and serves as 
an integration point for different MAPK pathways. Phosphorylation generally 
enhances the transcriptional activity of ets proteins leading to the increased 
affinity of the proteins to their DNA binding sites, like Ras response elements 
(RREs) or serum response elements (SREs) which are found in the 
promoters of many immediate early response genes. The identification of 
docking domains for MAPKs in ets proteins showed that the binding of 
MAPKs is specific for different substrate ets proteins (Fig.1.1, Sharrocks, 
2001). As mentioned above, ets proteins can be positive or negative 
regulators of transcription. Most ets proteins have been shown to be 
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transcriptional activators (see Table.1.1). Earlier studies showed that some 
factors such as ERF, NET, YAN and ETV6 act as transcriptional repressors 
(Sgouras et al., 1995; Lai et al., 1997; Wood et al., 2003). The identification 
of the repression domains of NET and ETV6 showed that their transcriptional 
repression functions depend in part on the recruitment of histone deacetylase. 
These four proteins are all regulated by MAPKs. Recently, it could be 
demonstrated that several ets family members function both as 
transcriptional activators and repressors. For examples, NET can change its 
repressor role to an activator when it is activated by Ras (Giovane et al., 
1994). Elk-1 was originally described as an activator protein, but recent 
studies revealed a repression domain at the N-terminus of Elk-1, which is 
highly homologous to the CRD1 repression domain of p-300 (Yang et al., 
2002; Yang et al., 2003b). Sumoylation of Elk-1 leads to transcriptional 
repression which depends on the histone deacetylase complex (Yang et al., 
2001; Yang et al., 2003a). 
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Fig. 1.1 ets proteins are regulated by phosphorylation. Sharrocks, 2001  
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1.1.2  Biological characterization of ETV6 
 
1.1.2.1 The ETV6 gene and its protein domains 
 
1.1.2.1.1 Cloning and characterization of ETV6  
 
ETV6 was cloned as the fusion partner of PDGFRβ from the leukemic cells of 
a patient with CMMoL in 1994 (Golub et al., 1994). The ETV6-PDGFRβ 
fusion gene is the result of a chromosomal translocation between 
chromosomes 12 and 5, t(5;12)(q33;p13). The ETV6 gene encodes two 
nuclear proteins, one of 452 amino acid residues, and the other of 409 amino 
acid residues which results when an alternative start cordon at position 43 is 
used. Human ETV6 is 85% homologous to mouse ETV6 (NCBI database). In 
the ETV6/PDGFRβ fusion gene, the sequence coding for the N-terminal 
portion of ETV6 including the pointed domain is fused to the C-terminal 
portion of PDGFRβ, which codes for the tyrosine kinase domain. 
Subsequently, more than 17 ETV6 fusion genes resulting from chromosomal 
translocations have been identified in different types of leukemias and also in 
some solid tumors. The ETV6 fusion partners include receptor tyrosine 
kinase such as PDGFRβ, JAK2, or transcription factors such as RUNX1 or 
CDX2 (Kim et al., 2001; Bohlander, 2000). 
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1.1.2.1.2 ETV6 protein domains  
 
Analysis of the ETV6 amino acid sequence revealed two domains, which are 
characteristic of ets proteins: an N-terminal pointed domain (SAM, 
helix-loop-helix (HLH) domain) and a C-terminal ets DNA binding domain. 
The pointed domain of ETV6 consists of 65 amino acids. The amino acids in 
this domain are highly conserved when compared to other pointed domains 
of ets proteins. This domain has been shown function as an oligomerization 
interface and mediates transcriptional repression through recruitment of the 
co-repressor L(3)MBT, a polycomb group protein. The ets domain of ETV6 is 
highly similar to the ets domain of other ets family members. The central 
domain of ETV6, which is the region between the pointed and the ets domain, 
has been shown to have repression function through the binding of the 
co-repressors SMRT, NcoR and mSin3A (Chakrabarti and Nucifora, 1999). 
The central domain is not conserved (Figure 1.2). 
 
Comparision of ETV6 from Fugu and human show that Fugu ETV6 is highly 
related to its human homologue with an overall amino acid identity of about 
58% (72% similarity) and that the pointed and ets domains of different 
vertebrate species (human, Fugu, chicken, mouse) are highly conserved with 
81% to 95% amino acid sequence identity (Montpetit and Sinnett, 2001). In 
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2000, a human gene with great similarities to ETV6 was described and 
named ETV7. ETV7 is located on chromosome 6 band p21 and encodes for 
a protein of 341 amino acids which has a pointed and an ets domain (Potter 
et al., 2000). 
 
Fig. 1.2  ETV6 structure. 
 
1.1.2.2 ETV6 function 
 
1.1.2.2.1 ETV6 in mammalian development 
 
The ETV6 gene is widely expressed in embryonic development and in the 
adult. Knock-out experiments have shown that ETV6 is not essential for 
embryonic hematopoiesis (Wang et al., 1998). Analysis of ETV6 expression 
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in mouse development shows that embryos express ETV6 at high levels in 
multiple organs including the developing lungs, kidneys and liver. High levels 
of ETV6 expression are also found in neural tissues, such as the cranial 
nerve ganglia, the dorsal root ganglia, the midbrain and the ventral region of 
the caudal neural tube. At mid-gestation, high expression of ETV6 is found in 
the fetal lungs, thymus, liver and abundantly in hematopoietic cell lineages. 
In adult tissues ETV6 is expressed in the heart, lungs, brain, spleen, liver, 
kidneys, testes and skeletal muscle (Table 1.3). In ETV6 knock out mouse 
embryos, the development of the erythroid and myeloid lineages proceeds 
normally. These studies showed that ETV6 is required for the development of 
the vascular network in the yolk sac and for the survival of selected cell types 
within the embryo proper. Mice with targeted disruption of ETV6 die between 
E10.5-E11.5 with defective yolk sac angiogenesis and intra-embryonic 
apoptosis of mesenchymal and neural cells (Wang et al., 1997). However, 
studies using chimeric mice consisting of ETV6 knock-out and ETV6 wild 
type cells demonstrated that ETV6 is important for the development of T and 
B cells (Fig. 1.3). These studies also showed that ETV6 is essential for 
establishing final hematopoiesis in the bone marrow and is crucial for the 
maintenance of hematopoietic stem and progenitor cells in the bone marrow 
compartment (Wang et al., 1998). ETV7, which is closely related to ETV6, is 
also expressed in hematopoietic tissues and has been shown to interact with 
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ETV6 (Potter et al., 2000; Poirel et al., 2000). 
 
regions tissue E10.5 E11.5 E12.5 E13.5 E14.5 E15.5 E16 E17.5 E18.0 E19.5 D1 D7 D14 D21 adult
                 
head brain                
                 
 lung                
chest heart                
 thymus                
                 
 liver                
abdomen spleen                
 kidney                
 sex organs                
 
Table 1.3 The expression of ETV6 in different organs, modified from 
(Maroulakou and Bowe, 2000) 
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Fig. 1.3  ETV6 expresses in hematopoietic and endothelial cell 
development. Modified from Maroulakou and Bowe. (2000) 
 
1.1.2.2.2 ETV6 fusion genes 
 
ETV6 was initially cloned as the fusion partner of PDGFRβ in a balanced 
chromosomal translocation involving chromosomes 5 and 12 band q33 and 
p13 (Golub et al., 1994). Subsequently, ETV6 has been found fused to 
numerous different genes in different types leukemia and in some solid 
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tumors. Up to now, some 35 different chromosome bands have been shown 
to be involved in ETV6 related translocation, which suggests that ETV6 is 
involved in at least 41 different chromosomal translocations (Odero et al., 
2001). Almost 20 different fusion partners of ETV6 have been found from 
protein tyrosine kinases, such as ARG, NTRK3/TRKC, PDGFRβ, JAK2, ABL, 
SYK, and FGFR3, to transcription factors, such as AML1/RUNX1, EVI1, 
HLXB9, MN1 or PAX5, to genes of various or unknown functions, such as 
STL, BTL, ARNT, MDS2, TTL, ACS2. Most cases of ETV6 fusion genes are 
found in patients with leukemia or certain solid tumors. 
 
The molecular mechanisms by which the various ETV6 fusion proteins cause 
leukemia are quite well understood in the case of the ETV6-tyrosine kinase 
(PTK) fusions and less well understood in the case of ETV6 transcription 
factor (TF) fusions or fusion with genes of unknown function. It could be 
shown that the pointed domain mediates dimerization or oligomerization of 
the ETV6-PTK fusion proteins which leads to constitutive activation of the 
PTK and aberrant signaling (Golub et al., 1996; Argani et al., 2000; Gloc et 
al., 2002; Atfi et al., 1999). Deletion of the pointed domain in the ETV6-PTK 
fusion abrogates the transforming properties of the fusion protein. In the two 
cases of ETV6-TF fusions that are well studied the pathogenic mechanism 
seems to be the formation of an aberrant transcription factor. This 
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mechanism is described in the next paragraph.  
  
1.1.2.2.3 ETV6 in transcriptional regulation 
 
Unlike most members of the ets family of transcription factors, which are 
activators of transcription and induce cellular transformation when 
over-expressed, ETV6 is a transcriptional repressor.  
 
Functional studies of ETV6 fusion genes show that these chimeric proteins 
behave as transcriptional activators or repressors depending on their fusion 
partner and on which domains of ETV6 are retained in the fusion protein. For 
example, the t(12; 22)(p13;q11) found in two patients (one with myeloid 
leukemia and one with myelodysplastic syndrome (MDS)), results in the 
formation of the MN1-ETV6 and ETV6-MN1 fusion genes. The MN1-ETV6 
fusion protein consists of the N-terminal portion of MN1 which is rich in 
prolines and has two polyglutamine stretches, and the C-terminus of ETV6 
with the ets DNA binding domain (Buijs et al., 1995). This chimeric protein, 
unlike ETV6 or MN1, transforms murine fibroblast NIH3T3 cells. The 
transformation potential depends on both the N-terminal MN1 portion and a 
functional ETV6 DBD, which is also essential for the transcriptional activity of 
the MN1-ETV6 fusion protein (Buijs et al., 2000).  
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The ETV6-AML1 fusion gene caused by the t(12;21)(p13;q22) originally 
described in two cases of childhood pre-B ALL encodes for a fusion protein 
which contains the pointed domain of ETV6 and the DNA binding and 
transactivation domain of AML1 (Golub et al., 1995). This fusion gene was 
later shown to be the most common fusion gene in childhood ALL (Shurtleff 
et al., 1995; Fears et al., 1996). The ETV6-AML1 fusion protein interacts with 
the Core-Binding Factor Beta (CBFβ), an AML1 binding protein. The 
ETV6-AML1 fusion protein represses transcription of a reporter gene under 
the control of the T-cell receptor beta enhancer, which is normally activated 
by AML1. The repression mediated by ETV6-AML1 is dependent on the 
pointed domain of ETV6 (Hiebert et al., 1996). This observation led to the 
identification of an association between ETV6 and the co-repressors mSin3A 
and SMRT. The pointed domain and the central region of ETV6 play a role in 
transcriptional repression using two different mechanisms. The central 
domain requires interaction with SMRT and mSin3A for its repressional 
activity. SMRT and mSin3A recruit histone deacetylase enzymes (HDAC) 
(Chakrabarti and Nucifora, 1999). Recently, it could be shown that the 
transcriptional repression mediated by the pointed domain of ETV6 requires 
interaction with the polycomb group gene L(3)MBT (Boccuni et al., 2003).  
 
Frequent unbalanced chromosomal translocations and deletions affecting 
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the the short arm of chromosome 12 in different hematopoietic malignancies 
suggest the presence of a tumor suppressor gene in this region. It could be 
shown that the minmal region of overlap of these deletions contains ETV6 
and the cyclin dependent kinase inhibitor KIP1 (Wang et al., 1997; Sato et al., 
1995; Hatta et al., 1997). In more than 70% of childhood acute lymphoblastic 
leukemias with an ETV6/RUNX1 fusion gene a deletion of the 
non-rearranged ETV6 allele is observed (Romana et al., 1996). These 
findings suggest that ETV6 is a tumor suppressor gene. However, direct 
evidence supporting this hypothesis is still lacking.  
 
Since ETV6 plays an important role in chromosomal translocations in 
different types of human leukemia and solid tumors and also has a prominent 
role mammalian hematopoietic development, a yeast two-hybrid screen was 
performed using ETV6 as bait. A HeLa cDNA library was used in this screen. 
The aim of this screen was to find more protein interaction partners of ETV6, 
which would provide more information about the function of ETV6. The 
screen was carried out by Sigrun Bartels, a technician in Prof. Bohlanders 
laboratory at the Human Genetics Institute in Göttingen in 1996. The 
following interaction partners were identified TIP60β (human HIV Tat 
interaction protein, Mw 60 KDa), PIN1 (protein interaction with NIMA1), and 
UBC9 (ubiquitin-conjugating enzyme 9) (Putnik, Ph.D. thesis, 2001). Several 
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of the experiments confirming the physical interaction between ETV6 and 
TIP60 or PIN1 were performed by Jasmina Putnik and Michael Kickstein 
(Putnik, Ph.D. thesis, 2001). The focus of the thesis work presented here is 
the detailed analysis of the functional consequences of the interaction of 
ETV6 with TIP60β and of ETV6 with PIN1.  
 
In the following paragraphs some background information on TIP60 and 
PIN1 is given. 
 
 
1.2 TIP60  
 
TIP60 was identified in a yeast two-hybrid screen in a human 
B-lymphoblastoid cDNA library as a HIV-1 Tat protein interacting partner. 
The human HIV Tat protein is important in activating HIV gene expression. 
TIP60 directly interacts with the HIV-1 Tat activation domain and acts as a 
Tat transcriptional co-activator on the HIV-1 promoter (Kamine et al., 1996). 
TIP60 is a member of the MYST family of histone acetyltransferases (HAT). 
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1.2.1 Histone acetyltransferases 
 
Eukaryotic transcription is a highly regulated process in which numerous 
protein factors participate. Acetylation plays an important role in this process 
for modifying the structure of chromatin through the acetylation of histone 
tails and through the direct acetylation of some transcription factors. Histone 
acetyltransferases (HAT) transfer acetyl groups from acetyl Co-enzyme A to 
the epsilon-amino groups of an amino-terminal lysine residue in the 
N-terminal tail of the core histone proteins (H2A, H2B, H3 and H4). Several 
non-histone transcription factors have also been shown to be modified by 
HATs in vitro and in vivo. All these observations show that HATs play a major 
role in transcriptional regulation (Sterner and Berger, 2000).  
 
HATs can be separated into at least two classes. Type A HATs are localized in 
nucleus and acetylate histones and some transcription factors to regulate 
gene expression. Type B HATs can be purified from cytoplasmic fraction and 
are involved in acetylating newly synthesized histones. Recent studies also 
show that type B protein HATs can also be found in the nucleus to regulate 
gene silencing (Sterner and Berger, 2000). 
 
HATs usually function as transcriptional co-activators. The exact nature of 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
24 
their transcriptional activation function is dependent on their interaction with 
different transcription factors. However, some HATs can act both as 
transcriptional co-activators and as transcriptional co-repressors (Sterner 
and Berger, 2000; Yang and Sharrocks, 2004; Yang, 2004).  
 
1.2.2  MYST domain proteins 
 
The MYST domain is an about 200 amino acid long highly conserved protein 
domain. The name MYST is an acronym derived from the names of the four 
founding proteins with this conserved domain: human MOZ (monocytic 
leukemia zinc finger protein) (Borrow et al., 1996), yeast Ybf2 (renamed 
Sas3, something about silencing 3), yeast Sas2 and human TIP60 (HIV 
Tat-interacting protein, 60 kDa) (Kamine et al., 1996). There are at least five 
MYST domain proteins in the human genome: TIP60, MOF, HBO1, MOZ and 
MORF. The MYST domain contains a C2HC zinc finger and a histone acetyl 
Co-enzyme A binding site which is responsible for the histone 
acetyltransferase catalytic activity of these proteins (Fig. 1.4 modified from 
(Yang, 2004)).  
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Fig. 1.4 Structure of human MYST domain proteins (modified from X-J. Yang, 
2004) 
 
MYST domain proteins can be found in various species from yeast, to 
Drosophila to mammals. Usually, the MYST proteins are found in large 
multiprotein complexes in vivo. For example, the complex in which the yeast 
Esa1 protein is found, NuA4, consists of at least 12 subunits. The NuA4 HAT 
complex is highly conserved in eukaryotes. It plays a role in regulation 
transcription, cellular response to DNA damage, and cell cycle progression 
(Doyon et al., 2004). MYST domain HATs have diverse regulatory functions 
in biological processes. This depends among other things on the other 
proteins they are associated with. Esa1 plays an important role in DNA repair 
and cell cycle progression (Clarke et al., 1999). The NuA4 protein complex 
*  acetyl co-enzyme A binding site Zinc finger 
*
*
*
*
*
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has also been shown to link spindle stress to transcription control (Doyon et 
al., 2004). MOZ and MORF contain both transcriptional repression and 
activation domains and might function both as co-activators and as 
co-repressors of transcription (Champagne et al., 1999; Champagne et al., 
2001).  
 
1.2.3  The structure and function of TIP60  
 
There are three protein isoforms of TIP60 resulting from alternative splicing: 
TIP60alpha, TIP60beta (Sheridan et al., 2001; Bohlander et al., 2001; Ran 
and Pereira-Smith, 2000) and a larger form of TIP60 (Legube and Trouche, 
2003). TIP60alpha is 513 amino acids long with a MYST domain at the 
C-terminus, a proline rich domain and a chromo domain at the N-terminus. 
TIP60beta is 461 amino acids in length and lacks 52 amino acids at the 
N-terminus. The larger form of TIP60 has 33 amino acids more than 
TIP60alpha at the N-terminus. A diagram of the three TIP60 isoforms is 
presented in Fig. 1.5.  
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Fig. 1.5  TIP60 isoforms 
 
Various studies have shown that the histone acetyltransferase TIP60 has a 
role in DNA repair, apoptosis and signal transduction. These studies were 
mainly performed with the TIP60α isoform.  
 
Initially, TIP60 was isolated as a protein that interacted with the essential 31 
amino acid residues at the N-terminus of the HIV1 Tat protein. This 
interaction causes a 4-fold increase of Tat transactivation of the HIV1 
promoter without increasing the basal activity of the HIV promoter or 
activating the heterologous RSV promoter (Kamine et al., 1996).  
 
The TIP60α isoform has been shown to be a part of a large protein complex 
in mammalian cells. This protein complex has histone acetylase activity on 
chromatin and is involved in ATPase, DNA helicase and structural DNA 
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binding activities (Ikura et al., 2000). A recent study showed that both TIP60α 
and TIP60β are both subunits of the human NuA4 protein complex, which 
has a similar HAT activity like the yeast NuA4 complex. There are 11 subunits 
conserved between the human and the yeast NuA4 complex. TIP60, EPC1 
and ING3 form the core of the NuA4 protein complex, which has a strong 
HAT activity on nucleosomal templates. Extrapolating from the role of the 
NuA4 complex in yeast, mammalian TIP60 in the NuA4 complex probably 
plays a key role in the regulation of gene expression and cell cycle 
progression (Ceol and Horvitz, 2004).  
 
Although subcellular localization data show that TIP60 is mainly a nuclear 
protein, there is also some data that suggests that TIP60 might have a role in 
signal transduction in the cytoplasm. TIP60 forms a protein complex in the 
cytoplasm with the intracellular tail fragment of the amyloid-beta precursor 
protein (APP) and the nuclear adaptor protein Fe65. This protein complex 
potentially activates transcription (Cao and Sudhof, 2001). Additional studies 
of this protein complex show that the membrane part of the APP intracellular 
domain (AICD) recruits Fe65 and mediates the activation of bound Fe65 that 
is then released by proteolytic cleavage and undergoes nuclear translocation 
together with the AICD (Cao and Sudhof, 2004). TIP60 has also been 
reported to interact with the cytoplasmic tail of the alpha chain of the human 
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interleukin 9 receptor (IL-9 Rα) (Sliva et al., 1999). TIP60 enhances 
Bcl-3-p50 dependent transcription through NF-kappa B binding sites (Baek et 
al., 2002) and is a co-activator of nuclear hormone receptors (Brady et al., 
1999; Halkidou et al., 2003).  
 
TIP60 has not only been shown to be a transcriptional co-activator, but has 
also been shown to be a transcriptional co-repressor depending on the 
proteins that it interacts with. When TIP60 is expressed as a GAL4DNA 
binding domain fusion (GAL4DBD) it represses the expression of a luciferase 
reporter gene, which is under the control of a thymidine kinase promoter and 
Gal4 DNA binding site. This repression can be enhanced by coexpression of 
HDAC7, which interacts with the zinc finger of the TIP60 MYST domain (Xiao 
et al., 2003). TIP60 interacts with STAT3 and represses STAT3-mediated 
gene expression. This repression can be further enhanced by co-transfection 
of HDAC7 (Xiao et al., 2003). Other HATs such as CBP/p300 and 
NcoA/SRC1a also play essential roles in STAT3-mediated transcriptional 
activation (Giraud et al., 2002). 
 
The interaction between ETV6 and TIP60 has been shown to result in 
co-repression in a reporter gene system using SEAP (secreted alkaline 
phosphatase) as a reporter. The SEAP reporter gene was under the control 
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of the beta-globin promoter, three ets binding sites, Gal4 binding sites and an 
ERE (oestrogen response element) (Nordentoft and Jorgensen, 2003). Our 
own data show similar results: a TIP60β-YFP fusion (YFP: yellow fluorescent 
protein) represses the transcription of a luciferase reporter gene which is 
under the control of a portion of the stromelysin-1 promoter containing an ets 
binding site and an ETV6 binding site (Zhang and Bohlander, 2003). 
 
The histone acetyltransferase activity of TIP60 is modulated in vivo by 
phosphorylation of TIP60 at two main phosphorylation sites (Ser86 and 
Ser90). S90 is specifically phosphorylated in vitro by the cyclin B/Cdc2 
complex. Phosphorylation of TIP60 was enhanced after drug-induced arrest 
of cells at G(2)/M (Lemercier et al., 2003). 
 
1.3  PIN1 
 
The other interacting partner of ETV6 found in the Hela cDNA library screen 
was PIN1 (protein interacting with NIMA1 (never in mitosis A)), a member of 
the parvulin family peptidyl-prolyl cis/trans isomerases. PIN1 was first 
identified as an interacting partner of NIMA1 in a yeast two-hybrid screen (Lu 
et al., 1996).  
 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
31 
1.3.1  Description of PIN1 
 
The PIN1 gene is located at chromosome 19 band p13 (Campbell et al., 
1997). It is highly conserved in evolution and thus found in numerous species 
from primitive chordates to mammals. PIN1 forms a new class of 
peptidyl-prolyl cis/trans isomerases together with other genes including the E. 
coli parvulin, yeast ESS1, and Drosophila melanogaster dodo gene. All these 
suggest that PIN1 plays an important role in basic cellular processes.  
 
Human PIN1 encodes a 163 amino acid long protein with two functional 
domains: the WW domain and the PPIase domain. Mouse PIN1 consists of 
165 amino acid residues, which have a very high homology to human PIN1 
especially in the two domains (NCBI database).  
 
The WW domain was first described in 1994 (Bork and Sudol, 1994). Since 
then, several studies have shown that it is an important functional domain for 
protein-protein interaction. Usually, WW domains consist of around 40 amino 
acids with two signature tryptophan (W) residues spaced at 20 to 22 amino 
acids, which have important roles in the structure and function of the WW 
domain. This domain can identify and bind to proline-rich motifs in other 
proteins. The WW domain in PIN1 is specialized on interacting with 
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phosphorylated Ser/Thr-Pro motifs. The N-terminus of the WW domain 
provides the binding site for the interaction with the substrate. 
Three-dimensional models of the PIN1 WW domain derived from x-ray 
crystallography and NMR studies provide evidence for these interactions 
(Bayer et al., 2003; Ranganathan et al., 1997). Furthermore, it could be 
shown that phosphorylation of Ser16 in the WW domain of PIN1 is essential 
for the interaction of PIN1 with its subtrates and its function in the cell cycle 
(Lu et al., 2002). The isolated WW domain of PIN1 has been shown to have a 
similar ability of binding the substrate like full length PIN1 (Landrieu et al., 
2001; Bayer et al., 2003). For the interaction between PIN1 and Cdc25C, the 
threonine phosphorylation at Thr48-Pro and Thr67-Pro is essential (Zhou et 
al., 2000). In p53, phosphorylation of three Threonine/Serine- Proline motifs 
(Thr23-Pro, Thr81-Pro and Ser315-Pro) are important for the interaction with 
PIN1 (Zacchi et al., 2002). 
 
The other functional domain on PIN1 is the PPIase domain. It spans 113 
amino acids from aa 50 to aa 163. The C-terminal portion of this domain 
contains the catalytic function for the peoptidyl-prolyl isomerization reaction 
of the substrate at the pSer/pThr-Pro peptide bonds. This conformational 
change in the substrate depends on the binding of substrate through the WW 
domain, which brings the substrate into close proximity to the PPIase 
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catalytic site. The isolated PPIase domain shows moderate affinity or no 
affinity towards to the substrates (Verdecia et al., 2000; Shen et al., 1998). 
The conformational changes of Cdc25C induced by PIN1 peptidly-prolyl 
cis-trans isomerization makes Cdc25 sensitive to cleavage by proteases or 
allows binding of MPM-2 (phosphospecific mitosis marker antibody) (Shen et 
al., 1998) (Fig. 1.6 ). 
 
Fig.1.6  The primary structure of PIN1 and some of its protein interacting 
partners 
The X-ray and NMR structures of PIN1 show that these two functional 
domains share a common interface. The WW domain and PPIase domain 
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are connected by a glycine and serine rich polypeptide chain (Kowalski et al., 
2002; Wintjens et al., 2001). Additional NMR studies of PIN1 and its 
substrates in solution demonstrate that the linker between these two domains 
contributes to substrate binding (Bayer et al., 2003).  
 
1.3.2   PIN1 function 
 
More than 20 interacting partners of PIN1 have been identified to date. These 
proteins belong to mitotic proteins, cytoskeleton proteins, transcription 
factors or cell cycle regulators. The interaction between PIN1 and its 
substrates causes a conformational change in the substrates, which affects 
their properties and functions such as phophorylation status, their 
interactions with other proteins, their subcellular localization or stability. For 
example, the conformational change of Cdc25 caused by PIN1 causes 
Cdc25 to become dephosphorylated and become subject to proteolytic 
cleavage (Shen et al., 1998; Stukenberg and Kirschner, 2001; Zhou et al., 
2000).  
 
PIN1 has been shown to be involved in the regulation of cell cycle 
progression, proliferation and differentiation. It is also involved in the 
transcriptional regulation of some genes in response to DNA damage 
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response through the regulation of TP53 function (Wulf et al., 2002). On a 
pathological level, PIN1 has been found to play a role in processes related to 
Alzheimer’s disease and is over-expressed in some solid tumors (Ayala et al., 
2003; Hamdane et al., 2002; Joseph et al., 2003; Shaw, 2002; Uchida et al., 
2003; Wulf et al., 2003). 
 
PIN1 has been shown to be important for the regulation of several cell cycle 
transitions including the G1/S and G2/M transitions. It also plays a role in the 
DNA replication checkpoint (Winkler et al., 2000; Wulf et al., 2002). Depletion 
of PIN1 causes mitotic arrest and apoptosis in yeast and HeLa cells (Lu et al., 
1996). The interaction between cell cycle regulator Cyclin D1 and PIN1 has 
been studied in vitro and in vivo. Cyclin D1 is overexpressed in one half of 
breast cancer and contributes to cellular transformation. In the Cyclin D1 
overexpressing tumors such as breast cancer, PIN1 is also expressed two 
times as high as in CyclinD1 negative tumors (Tsuchida et al., 2003). 
 
PIN1 overexpression has been described not only in breast cancer but also 
in other solid tumors like lung, prostate cancers, oral squamous cell 
carcinoma and thyroid tumor (Nakashima et al., 2004; Miyashita et al., 2003). 
The expression level of PIN1 is positively correlated to tumor grade in breast 
cancer (Wulf et al., 2001).  
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TP53, a known tumor suppressor, plays a pivotal role in cell cycle 
checkpoints, genomic stability and apoptosis (Chang, 2002). DNA damage 
causes the stabilization and accumulation of TP53, which is dependent on 
TP53 phosphorylation at multiple Ser/Thr residues. The role of PIN1 in DNA 
damage response is mediated through regulation of TP53. DNA damage 
enhances the specific interaction between PIN1 and TP53 through binding of 
the PIN1 WW domain to phosphorylated Ser-Pro or Thr-Pro motifs in TP53. 
The conformational change of TP53 catalyzed by PIN1 through 
peptidyl-prolyl cis-trans isomerization leads to a reduced affinity of TP53 for 
its ubiquitin ligase, MDM2. This in turn increases TP53 half life by reducing 
proteasomal degradation of TP53 (Yang et al., 2004).  
 
The phosphorylation of proteins at Ser/Thr-Pro residues is an important 
signaling mechanism in many cellular processes. It is regulated by a large 
superfamily of serine-threonine kinases such as cyclin-dependent kinases 
(CDKs), mitogen-activated protein kinases (MAPKs) and glycogen synthase 
kinase 3 beta. The discovery that PIN1 changes the conformation of 
phosphorylated Ser/Thr-Pro bonds in target proteins revealed a new 
post-phosphorylation regulatory mechanism of cellular signaling (Ryo et al., 
2003). 
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1.4  Aim of this study 
 
It is the aim of this work to analyze the interactions of ETV6 with TIP60β and 
of ETV6 with PIN1. In particular, how the interaction with these two proteins, 
a MYST domain histone acetyltransferase and a peptidyl-prolyl cis trans 
isomerase, changes the function of ETV6 as a transcriptional repressor. 
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2.   Materials 
 
 
2.1 Chemicals, enzymes 
 
2.1.1 Chemicals 
 
100bp DNA Ladder  BibcoBRL Life technologies, USA 
1Kb DNA Ladder  BibcoBRL Life technologies, USA 
3-amino-1, 2, 4-triazole (3-AT)        Sigma, Germany  
Acetic acid  Roth, Germany 
Acrylamide  Roth, Germany 
Agar  Roth, Germany  
Agarose  Roth, Germany 
Albumin bovine fraction V  Sigma, Germany 
Ampicillin  Roth, Germany 
Bacto-peptone  Difco, USA 
Bacto-yeast extracts  Difco, USA  
BioRad protein assay  BioRad, USA 
Bis-acrylamide  Roth, Germany  
Boric acid  Roth, Germany 
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Bromophenol blue  Roth, Germany  
BSA (bovine serum albumin)  Roth, Germany 
Calcium chloride dihydrate  Roth, Germany 
Coomassie Blue. G250 Brilliant Blue  Roth, Germany 
D-Galactose  Sigma, Germany 
Diethyl-1, 3, 6, 8-tetrahydro-1, 3, 6, 8- 
tetraoxobenzo[lmn][3,8] phenanthroline- 
2,7-diacetate (DTTPD)  Calchem, UK 
Dithiothreitol (DTT)  Roth, Germany 
Dulbecco’s modified eagle medium 
(DMEM)  PAN, Germany 
Dimethylformamaide (DMF)  Merck, Germany 
Dimethyl Sulfoxid (DMSO)  Sigma, Germany 
DPBS  PAN, Germany 
ECL Hyperfilm  Amersham-Pharmacia, UK 
Ethylenediaminetetraacetic acid (EDTA)  Roth, Germany  
Ethanol  Merck, Germany 
Ethidium Bromide Roth, Germany 
Fetal calf serum (FCS) PAN, Germany; Gibco, USA 
Fish sperm DNA  Sigma, Germany 
Formalddehyde 37%  Roth, Germany 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
40 
Glycerin (Glycerol)  Roth, Germany 
Glucose  Merck, Germany  
Glutathione-Sepharose 4B  Amersham-Pharmacia, UK 
HCl  Roth, Germany 
Hoechst 33342  Sigma, Germany 
Hybond-ECL (Nitrocellulose)  Amersham-Pharmacia, UK 
IPTG (Isopropyl-1-thio- 
β-D-galactopyranoside)  Roth, Germany 
Isopropanol  Roth, Germany 
K2HPO4  Roth, Germany 
Kanamycin  Roth, Germany 
L-amino acids 20 types  Sigma, Germany 
L-Glutamine  Sigma, Germany  
Lithium acetate (LiAc)  Sigma, Germany 
2- Mercaptoethanol (2-ME)  Sigma, Germany 
Methanol  Merck, Germany 
Milk powder  Roth, Germany 
Magnesium chloride hexahydrate  Roth, Germany 
Magnesium sulphate heptahydrate  Roth Germany 
NP-40 Sigma, Germany 
PBS (phosphate-buffered saline)  PAN, Germany 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
41 
PEG (polyethylene glycol) 4000  Sigma, Germany 
Penicillin/Streptomycin  PAN, Germany 
PMSF (Phenylmethylsulfonyl fluoride)  Sigma, Germany 
Poly-Lysine  Sigma, Germany 
Propidium iodide (PI) Sigma, Germany 
Protease inhibitors  Sigma, Germany 
Protein A agarose  Santa Cruz, USA 
Protein A/G PLUS-Agarose  Santa Cruz, USA 
Protein G agarose  Santa Cruz, USA 
Roti-Fect  Roth, Germany 
SeeBlue protein standards  BD, Germany 
Sepherose 4B beads  Amersham-Pharmacia, UK 
SDS (sodium dodecyl sulphate)  Roth, Germany  
Sodium acetate  Sigma, Germany 
Sodium azide  Roth, Germany 
Sodium chloride  Roth, Germany 
Sodium deoxycholade Sigma, Germany 
Sodium di-hydrogen  
phosphate-monohydrate  Roth, Germany 
Sodium fluoride  Sigma, Germany 
Sodium orthovanadate  Aldrich, Germany 
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TEMED  Roth, Germany 
Trichostatin A  Sigma, Germany 
Tris base  Roth, Germany  
Triton X-100  Roth, Germany 
Trypsin/EDTA  PAN, Germany  
Tryptone  Roth, Germany 
Tween 20  Roth, Germany 
X-gal (5-Bromo-4-chloro- 
3-indoyl-β-D-galactopyranoside)  Roth, Germany  
Yeast extracts  Difco, USA 
Yeast nitrogen base  Difco, USA 
ZnSO4·7H2O  Merck, Germany 
 
2.1.2 Enzymes for DNA manipulation 
 
Klenow fragment  MBI-Fermentas, USA  
DNA restriction endouncleases  MBI-Fermentas, USA 
RNAse A  Qiagen, Germany 
T4 DNA Ligase  Gibco, USA 
T4 DNA Polymerase  MBI-Fermentas, USA 
rTaq® DNA Polymerase  PAN, Germany 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
43 
2.2  Commercial kits 
 
Dual-Luciferase® Reporter Assay  
System  Promega, USA 
ECL Westernblotting Detection  
Reagents Kit  Amersham-Pharmacia, UK 
GeneAmp PCR Reagent Kit  Perkin Elmer USA 
Qiagen Plasmid Mini Kit  Qiagen GmbH, Germany 
Qiagen Plasmid Maxi Endo-free Kit  Qiagen GmbH, Germany 
Qiaquick Gel-Extract Kit  Qiagen GmbH, Germany  
QuikChange® Multi Site-Directed  
Mutagenesis Kit   Stratagene, USA 
 
 
2.3 Labware and Equipment 
 
FACS (Moflo (Modular Flow Cytometer)) Cytomation, USA 
Sterile filter 0.22 µm  Roth, Germany 
Micro-pestle 100-1000 µl  Roth, Germany 
Fluorescent Microscope  Karl Zeiss, Germany 
TD-20/20 Luminometer  Turner Designg, Germany 
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Whatmann 3MM paper  Whatmann, USA 
 
2.4 Bacterial and yeast strains 
 
2.4.1      Bacterial strains 
 
E.coli strains XL1-Blue  Stratagene, USA  
E.coli strains XL10-Gold  Stratagene, USA 
E.coli strains BL21  Amersham-Pharmacia, UK 
 
2.4.2 Yeast strains 
 
CG-1945 (Clontech, USA) was used in yeast two-hybrid screening and 
protein-protein interaction model in yeast with a highly sensitive HIS3 
reporter gene and a lacZ reporter gene. It has the genotype: MATa, ura3-52, 
his3-200, ade2-101, lys2-801, trp1-901, leu2-3,  
112, gal4-542, gal80-538, cyhr2, LYS2::GAL1UAS-GAL1TATA-HIS3, URA3:: 
GAL417-mers(x3)-CYC1TATA-lacZ. 
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2.5 Mammalian cell lines 
 
HEK 293T (Human embryonal kidney adherent fibroblastoid cells growing as 
monolayer), from DSMZ-Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmbH 
NIH 3T3 (Swiss mouse embryo fibroblast adherent monolayer cells), from 
DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH 
 
2.6 Plasmids and oligonucleotides 
 
2.6.1 Cloning vectors 
 
Plasmid 
name 
Used for Company 
pCMV-3B 
Expressing a myc tag fusion protein in 
mammalian cells 
Stratagene, USA
pCMV-2A 
Expressing a flag tag fusion protein in 
mammalian cells 
Stratagene, USA
pGAD-424 
Expressing a GAL4 DNA activation 
domain fusion protein in yeast 
Clontech, USA 
pGBT9 Expressing a GAL4 DNA binding domain Clontech, USA 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
46 
fusion protein in yeast 
pECFP-C1 
Expressing a cyan fluorescence fusion 
protein in mammalian cells 
Clontech, USA 
pEYFP-N1 
Expressing a yellow fluorescence fusion 
protein in mammalian cells 
Clontech, USA 
pGEX4T2 
Expressing a GST fusion protein in 
bacteria 
Amersham, UK 
pM1 
Expressing a GAL4 DNA binding domain 
fusion protein in mammalian cells 
Promega, USA 
  
2.6.2 Oligonucleotides used 
 
2.6.2.1 DNA amplification primers: 
 
ETV6(964-1032) fragment amplification primers: 
 
Tel 964 Eco-T: 
 5’-GTGACGTCGACTGCTATTCTCCCAAT-3'  
ETV6 1032B SAL1: 
 5’- CTCTGAATTCTACATG AACCACATCATGGTC -3' 
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ETV6(964-1047) fragment amplification primers: 
Tel 964 Eco-T: 
 5’-GTGACGTCGACTCAAAGCAGTCTACAGT-3' 
ETV6 1047B SAL1: 
 5’- CTCTGAATTCTACATG AACCACATCATGGTC -3' 
 
For the amplification of full length PIN1 gene: 
 
PIN1ATGXhol:  
 5’-CACCTCGAGGGAAGATGGCGGACGAGGAGAAGCTGCCGCCC-3’ 
 
PIN1B498EcoRI:  
 5’-ACAGAATTCTCTCAGTGCGGAGGATG- 3’ 
 
For the amplification of full length TIP60 gene: 
TIP60ATGXhol:  
 5’-CATCTCGAGAAGATGGCGGAGGTGGGGGAGATAATCGAGGGC-3’ 
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TIP60B1765EcoRI:   
 5’-GTAGAATTCGCCACTTCCCCCTCTTG-3’ 
 
2.6.2.2 Sequencing primers: 
 
z EGFP-C1(1240-1258): 5’- AAA GAC CCC AAC GAG AAG C-3’ 
z DsRed-C 1(1214-1231): 5’-ACA TCA CCT CCC ACA ACG-3’ 
z PEYFPN-1(513-534): 5'-CATTGACGCAAATGGGCGGTAG-3' 
z Y2H1: 5’-TCATCGGGAAGAGAGT-3’ 
z Y2H2: 5’-TACCACTACAATGGATG-3’ 
z TIP-MYST 1270T: 5’-TCT CGA ATT CTA TGA CTG TAA GGG CTT CAA 
C-3’ 
z TIP505B: 5’ CAC CTG TCG ACC ACC TCT CAC TCT GGA GAG CC-3’ 
 
2.6.2.3 Site-directed mutagenesis primers: 
 
ETV6 mutagenesis primers: 
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ETV6(S106A): 
 
ETV6(S106A) T:  
 5 ' -ACTTTCGCTATCGAGCCCCTCATTCAGGT-3 ' 
ETV6(S106A) B: 
 5 ' -ACCTGAATGAGGGGCTCGATAGCGAAAGT-3 ' 
 
ETV6(S257A): 
 
ETV6(S257A) T: 
 5’-ACCCGAAGCCATCCGCACCCCGGCAGGAG-3’ 
ETV6(S257A) B: 
 5’-CTCCTGCCGGGGTGCGGATGGCTTCGGGT-3’ 
 
ETV6(S323A): 
 
ETV6(S323A)-T:  
 5’-TCATGGTCTCT GTC GCC CCG CCT GAA GAG -3’ 
ETV6(S323A)-B:  
 5’- CTC TTC AGG CGG GGC GAC AGA GAC CATGA-3’ 
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TIP60β mutagenesis primers: 
 
TIP60-DRS-T:  
 5’-CCTACCAGCGCCGGGACTACCGGAAGCTGAGCATCGAGTTCAG
C 3’ 
TIP60-DRS-B:  
 5’-GCTGAACTCGATGCTCAGCTTCCGGTAGTCCCGGCGCTGGTAG
G-3’ 
 
2.6.3 Constructs used in experiments 
 
No. Plasmids Antibiotics resistant Insert Obtained from 
1 pCMV-3B ETV6 Ampicillin ETV6 Michael Kickstein, 2000 
2 pGBT9 ETV6 Ampicillin ETV6 Sigrun Bartels, 1997 
3 pGAD424 ETV6(1-59) Ampicillin ETV6(1-59) Michael Kickstein, 2000 
4 pGAD424 ETV6(1-126) Ampicillin ETV6(1-126) Michael Kickstein, 2000 
5 pGAD424 ETV6(118-345) Ampicillin ETV6(118-345) Michael Kickstein, 2000 
6 pGAD424 ETV6(118-218) Ampicillin ETV6(118-218) Michael Kickstein, 2000 
7 pGAD424 ETV6(219-287) Ampicillin ETV6(219-287) Michael Kickstein, 2000 
8 pGAD424 ETV6(282-345) Ampicillin ETV6(282-345) Michael Kickstein, 2000 
9 pGAD424 ETV6(314-336) Ampicillin ETV6(314-336) Chang-Dong Zhang, 2002 
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10 pGAD424 ETV6(314-341) Ampicillin ETV6(314-341) 
Chang-Dong 
Zhang & Michael 
Kickstein, 2000, 
Chang-Dong 
Zhang, 2002 
11 pGAD424 ETV6(340-420) Ampicillin ETV6(340-420) Michael Kickstein, 2000 
12 pECFP C1 Kanamycin  Clontech 
13 pECFP C1 ETV6(S106A) Kanamycin ETV6(S106A) Chang-Dong Zhang, 2004 
14 pECFP C1 ETV6(S257A) Kanamycin ETV6(S257A) Chang-Dong Zhang, 2004 
15 pECFP C1 ETV6(S323A) Kanamycin ETV6(S323A) Chang-Dong Zhang, 2003 
16 pECFP C1 ETV6 Kanamycin ETV6 
Chang-Dong 
Zhang & Britta 
Kaltwasser, 
2001 
17 pM1 ETV6 Ampicillin ETV6 Sigrun Bartels, 1996 
18 pM1 ETV6(282-345) Ampicillin ETV6(282-345) Sigrun Bartels, 1996 
19 pM1 ETV6(S323A) Ampicillin ETV6(S323A) Chang-Dong Zhang, 2002 
20 pCMV 2A TIP60β Kanamycin TIP60β Michael Kickstein, 2000 
21 pEYFP C1 TIP60β Kanamycin TIP60β Chang-Dong Zhang, 2001 
22 pEYFP N1 TIP60β Kanamycin  TIP60β Chang-Dong Zhang, 2002 
23 pDasRed C1 Kanamycin  Clontech 
24 pDasRed C1 TIP60β Kanamycin TIP60β Chang-Dong Zhang, 2001 
25 pGEX4T2 TIP60β Ampicillin TIP60β Jasmina Putnik, 1998 
26 pGAD GH TIP60β Ampicillin TIP60β Hela cDNA library, Clontech 
27 pGAD GH TIP60β DRS Ampicillin TIP60β DRS Chang-Dong Zhang, 2001 
28 pEYFP N1 PIN1 Kanamycin PIN1 Chang-Dong Zhang, 2002 
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29 pGAD GH PIN1 Ampicillin PIN1 Hela cDNA library, Clontech 
30 pGAD424 PIN1 WWD Ampicillin PIN1 WWD Michael Kickstein, 2000 
31 pGAD424 PIN1 PPIase Ampicillin PIN1 PPIase Michael Kickstein, 2000 
32 pGAL4-TK Luc Ampicillin 
GAL4 DB, TK 
promoter, firefly 
luciferase 
Jasmina Putnik, 
1998 
33 pTR 89 Ampicillin luciferase Hiebert S.W., 2000 
34 pTR 334 Ampicillin 
stromelysin-1 
promoter, 
luciferase 
Hiebert S.W., 
2000 
35 phRL-null Ampicillin Renilla luciferase Clontech 
 
2.7 Media and cell culture  
 
2.7.1 Medium for E.coli 
 
LB (Luria Bertani) medium contains 10 g/l tryptone, 5 g/L yeast extract and 5 
g/L NaCl, pH 7.2. LB/Ampicillin medium was used for selecting the 
transformed colonies of Ampicillin resistant plasmids with a final 
concentration of 50 µg/ml Ampicillin.  
LB/ Kanamycin medium was used for selecting the transformed colonies of 
Kanamycin resistant plasmids with a final concentration of 25 µg/ml 
Kanamycin. 
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NZY+ medium consisted of 10 g/l NZ amine (casein hydrolysate), 5 g/l yeast 
extract, 5 g/l NaCl, pH 7.5, to 1 liter of meduim prior to use the following 
supplements were added: 12.5 ml of 1 M MgCl2 to a final concentration of 
12.5 mM, 12.5 ml of 1 M MgSO4 to a final concentration of 12.5 mM, 20 ml of 
20% (w/v) glucose (or 10 ml of 2 M glucose) to a final concentration of 20 mM. 
NZY+/Ampicillin and NZY+/Kanamycin medium was used for selecting site 
directed mutagenesis clones. For plates, 18g/l agar was added to the 
medium. 
  
2.7.2 Yeast Medium 
 
YPD medium was used for culturing CG1945 yeast strain to make competent 
cells for plasmid DNA transformation. YPD medium: 20 g/L peptone, 10 g/l 
yeast extract, pH5.8. After autoclaving, glucose was added to a final 
concentration of 2% at 55°C. For plates, 20 g/l agar was added to the 
medium.  
  
2.7.3 SD (synthetic drop-out) medium  
 
Synthetic drop-out medium was used to test for yeast autotrophy after 
transformation and for the expression of reporter genes that would indicate 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
54 
protein-protein interaction. SD medium: 6.7 g/l yeast nitrogen base, 20 g/L 
agar, 100 ml of appropriate 10x dropout stock solution, pH5.8. After 
autoclaving, glucose was added to a final concentration of 2% (w/v) and 3-AT 
was added to a final concentration of 0.1 mM, 0.5 mM, 1 mM, 2.5 mM or 5 
mM at 55 °C. Plates containing 3-AT were stored at 4°C for up to 2 months. 
2.7.4 Medium for mammalian cell culture 
 
Dulbecco’s Modified Eagle Medium (DMEM) with 4.5 mg/ml Glucose, 10% 
FCS, 2 mM Glutamine was used for HEK 293T and NIH 3T3 cells. For some 
experiments, Penicillin/Streptomycin was added in the medium at the final 
concentration of 1% (10.000 U/ml Penicillin and 10 mg/ml Streptomycin).  
 
2.8 Stock solutions and buffers 
 
The stock solutions listed below were all prepared with deionized H2O. “x” 
refers to the fold concentration of the stock solution. 
 
3-AT 
 
1 M 3-AT was prepared in deionized H2O, filter sterilized and stored at 4 
°C.  
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Dropout Solution (10X) for SD medium 
 
10x –Leu/–Trp DO Solution (lacking leucine and tryptrophan):  
 
200 mg adenine hemisulfate 
200 mg arginine HCl 
200 mg histidine HCl monohydrate 
300 mg isoleucine 
300 mg lysine HCl 
200 mg methionine 
500 mg phenylalanine 
2000 mg threonine 
300 mg tyrosine 
200 mg uracil 
1500 mg valine 
Components were dissolved in 1 L deionized H2O and autoclaved. 
 
10x –Leu/–Trp/-His DO Solution (lacking leucine, tryptrophan and histidine) 
 
200 mg adenine hemisulfate 
200 mg arginine HCl 
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300 mg isoleucine 
300 mg lysine HCl 
200 mg methionine 
500 mg phenylalanine 
2000 mg threonine 
300 mg tyrosine 
200 mg uracil 
1500 mg valine 
Components were dissolved in 1 L deionized H2O and autoclaved. 
 
IPTG (10mM) 
 
24 mg of isopropyl-1-thio-β-Dgalactopyranoside (IPTG) were dissolved in 
10 ml of sterile dH2O and stored at –20 °C. 
 
Laemmli-buffer (2 x)  
 
187.5 mM  Tris-Cl pH 6.8 
6 %  SDS 
30 %  Glycerol 
0.01 %  Bromophenol Blue 
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5 %  2-ME 
 
LiAc (10 x) 
 
1 M  LiAc-Hac 
pH7.5, autoclaved  
 
P1 buffer (resuspension buffer) 
 
50 mM  Tris·Cl 
10 mM  EDTA 
100 µg/ml  RNase A  
pH 8.0, stored at 2–8°C 
 
P2 buffer (lysis buffer) 
 
200 mM  NaOH  
1%  SDS (w/v) 
 
P3 buffer (neutralization buffer) 
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3.0 M  potassium acetate 
pH 5.5 
 
PBS (10 x) 
 
1.4 M  NaCl 
27 mM  KCl 
100 mM  Na2HPO4 
18 mM  KH2PO4 
pH7.3  
 
PEG 4000 (50%) 
 
50 g PEG4000 was dissolved in 100 ml H2O and autoclaved 
 
RIPA buffer 
 
1% (v/v)  NP40  
0.5%(w/v)  Deoxycholate  
0.1%(w/v)  SDS  
0.15 M  NaCl  
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5mM  EDTA  
50 mM  Tris  
pH 8.0  
 
TBE (5 x) 
 
0.45 M  Tris-Borate 
0.01 M  EDTA 
pH8.3, autoclaved 
 
TBS (10 x) 
 
0.2 M  Tris base  
1.5 M  NaCl  
pH7.4, autoclaved  
  
TE (10 x) 
 
0.1 M  Tris-HCl 
0.01 M  EDTA 
pH 7.5, autoclaved 
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TFB I 
 
10 mM  MES  
45 mM  MnCl2 4H2O  
10 mM  CaCl2 2H2O  
100 mM  KCl  
3 mM  Hexamminecobalt chloride  
filter sterilized and stored at 4 °C 
 
TFB II 
 
10 mM  KAc  
45 Mm  MnCl2 4H2O  
10 mM  CaCl2 2H2O  
10 mM  KCl  
100 mM  Hexamminecobalt chloride  
10%(v/v) Glycerol  
pH 6.4. filtered and stored at 4 °C. 
TSA (Trichostatin A) 
 
100 mM  TSA 
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Stored at -20 °C 
 
X-Gal (2%) 
 
0.2 g of 5-bromo-4-chloro-3-inodlyl-β-Dgalactopyranoside (X-Gal) was 
dissolved in 10 ml of dimethylformamide (DMF), stored at –20 °C 
 
2.9 Antibodies 
 
The following primary antibodies were used either in immunoblot analysis or 
as primary antibodies in immunoprecipitation. 
 
2.9.1 Primary antibodies: 
 
GFP antibody (A11122, Molecular Probes, Germany): 
 
Rabbit polyclonal IgG with a stock concentration of 2 mg/ml. This antibody 
was used for testing the expression of CFP fusion ETV6, YFP fusion 
TIP60β and YFP fusion PIN1 in transient transfection experiments. 
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Primary antibodies from Santa Cruz, USA: 
 
TEL/ETV6 (N-19): sc-8546  
Goat polyclonal IgG at a stock concentration of 200 µg/ml. This antibody 
was used to test the ETV6 protein expression in transiently transfected 
mammalian cells lysate. 
TIP60 (N-17): sc-5725  
Goat polyclonal IgG at a stock concentration of 200 µg/ml. This antibody 
was used to test the TIP60β expression in transiently transfected 
mammalian cells. 
PIN1 (H-123): sc-15340  
Rabbit polyclonal IgG with a stock concentration of 200 µg/ml. This 
antibody was used to test PIN1 expression in mammalian cells. 
 
2.9.2 Secondary antibodies: 
 
The following HRP-conjugated secondary antibodies from Santa Cruz were 
used in conjunction with the ECL Kit (Amershan Pharmacia, UK) to visualize 
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proteins in immunoblot (Western blot) analysis: 
 
Donkey anti-goat IgG HRP: sc-2056  
Donkey anti-rabbit IgG-HRP: sc-2305  
 
2.10 Softeware used 
 
Adobe photoshop 
 
This image manipulation software was mainly used to change the size and 
improve the contrast of experimental images. 
 
MacVector  
 
This software was used analyze the secondary structure (hairpin etc.) and 
annealing temperature of PCR primers. It was also used for comparing the 
homology between the target DNA and sequenced DNA. Some protein 
characteristics such as isoelectric point (PI), molecular weight (MW) were 
analyzed by this software.  
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Openlab  
 
This image analysis software was used to capture images (bright field and 
fluorescent) from the CCD attached to the Zeiss inverted microscope. It was 
also used to acquire Z- stacks of cells and to deconvolve theses images.  
 
WinMDI2.8 
 
It was used to analyze FACS data. 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
65 
3. Methods 
 
 
3.1 Molecular Biology 
 
3.1.1 Preparation and purification of plasmid DNA from bacteria 
 
The procedures were based on the alkaline lysis method with some 
modifications. Mini preparation was performed by following the modified 
protocol of QIAprep Spin Miniprep Kit without QIAprep Spin Column. The 
mini preparation plasmids were used as templates for DNA sequencing. 
Plasmid Midi and Max preparations were carried out with commercial kits 
from Qiagen. The process followed the manuals provided with the kits. The 
Plasmid Midi Kit was used to purify up to 100 µg of plasmid DNA. The 
Endo-free plasmid Max preparation Kit was used to obtain endotoxin-free 
plasmid DNA for transfection into mammalian cell. The following is a sample 
process of preparation and purification of a plasmid DNA minipreparation.  
Procedure: 
 
1. A single fresh colony was cultured in 4 ml LB medium containing the 
appropriate selective antibiotic at 37°C overnight with vigorous shaking. 
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2. The cells were harvested by centrifugation and resuspended with 300 µl 
buffer P1 in a 1.5 ml centrifugation tube. 
3. 300 µl buffer P2 was added and mixed gently. 
4. 300 µl buffer P3 was added and mixed gently. 
5. The tube was centrifuged at 12000 g for 10 minutes. 
6. The clear supernatant was moved to a new 1.5 ml centrifugation tube. 630 
µl isopropanol was added and mixed.  
7. The tube was centrifuged again at 12000 g for 10 minutes. The 
supernatant was discarded.  
8. 1 ml 70 % ethanol was added to wash the plasmid DNA pellet. The tube 
was centrifuged at 12000 g for 10 minutes. The supernatant was carefully 
removed. 
9. The tube was air-dried for 10 minutes. 10 µl TE buffer was added to 
dissolve the plasmid DNA pellet.  
10. The tube with plasmid DNA sample can be stored at 4 °C for one month 
or –20 °C for several years.  
 
3.1.2 Digestion of DNA with restriction endonucleases 
 
The restriction digestions were performed by the protocol provided by the 
supplier companies. For example, 1 µg plasmid DNA was digested with 5 
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units of a given enzyme and 1x digestion buffer in 20 µl total volume for an 
incubation of one hour at 37°C.  
 
3.1.3 Blunt ending 3’ or 5’ overhangs 
 
It was occasionally necessary to fill in the recessed 3’ ends of DNA molecules 
left after the digestion with restriction enzyme in some cloning experiments 
by using Klenow fragment in the reaction. For example, a single digestion 
was performed at first then the reaction mixture was incubated at the 
appropriate temperature to inactivate the first enzyme inactive. 5 units of 
Klenow and dNTP were mixed with reaction products and incubated at room 
temperature for 15 minutes or longer. Then the reaction was incubated at 65 
°C for 10 minutes to inactivate the Klenow enzyme. The blunted DNA product 
could be purified by QIAquickGelExtractionkit (Qiagen, USA). 
 
3.1.4  Polymerase chain reaction (PCR) 
 
3.1.4.1  Amplification of DNA fragments by PCR 
 
DNA amplification in the polymerase chain reaction (PCR) is based on 
multi-cycles of the denaturation of double stranded template (plasmid), 
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primer annealing and synthesis of new DNA sequence with a heat stable 
DNA polymerase. The following table is an example of standard reaction 
conditions for PCR, the total reaction volume is 20 µl. 
 
Tris HCl 
pH 8.3  Mg
2+ KCl dNTP Primers DNA polymerase Template DNA
10 mM 1.5 mM 50 mM 200 µM 1 µM 1-5 units 1 pg to 1 µg 
 
The denaturation, annealing and polymerization times and temperature are 
shown in the table below. 
 
Loop 1st 2nd 3rd  
Temperature 94 °C 94 °C 58 °C 72 °C 72 °C 4 °C 
Time 2 min 30 sec 30 sec 1 min 10 min ∞ 
Cycle x1 x25 x1  
 
 
3.1.4.2  Sequencing PCR reaction 
 
Cycle sequencing was performed using the dye dideoxy chain termination 
method based on the original dideoxy chain termination method developed 
by Sanger. In this work, it was performed by using pre-prepared solutions 
from a kit (Perkin Elmer (PE) Company) as listed below. 
 
BigDye Primer Template H2O Total Volume 
4 µl 1 µM 1 µg 4 µl 10 µl 
 
The denaturation, annealing and polymerization times and temperature are 
shown in below table. 
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Loop 1st 2nd 3rd 
Temperature 96 °C 96 °C 50 °C 60 °C 4 °C 
Time 1 min 30 sec 15 sec 4 min ∞ 
Cycle x1 x25 x1 
  
3.1.5  Site-directed mutagenesis of DNA  
 
Site-directed mutagenesis technique is an important tool for studying gene 
and protein function in vivo and vitro. The method is used to specifically 
mutate a nucleotide in a DNA sequence. In this work, the quick-change site 
directed mutagenesis method was used to obtain mutant plasmids. It was 
based on a three step (mutagenesis primer design, Dpn I digestion and 
mutant ss-DNA repair in vivo) protocol from Stratagene. 
 
3.1.5.1 Primer design for site directed mutagenesis 
 
The mutagenic oligonucleotide primers were designed to incorporate the 
desired point mutations and bind to adjacent sequences of the template 
plasmids. The length of primer should be between 25 and 45 bases with the 
melting temperature at least 75 degree. The GC percent of the whole primer 
should be more than 40% and at least one C or G at 3’ terminal. 
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3.1.5.2 Process of PCR 
 
PCR with the primers carrying the mutation was performed according to the 
manufacturer’s protocol with some modification as listed below.  
 
Reaction components, total volume were 20 µl: 
 
 
10 x 
reaction 
buffer 
H2O 
Qucik 
solution 
Plasmid DNA 
template 
Mutagenesis 
primers dNTP 
PfuTurbo 
DNA 
polymerase 
2 µl 14 µl 0.5 µl 1µl (100 ng/µl) 1 µl (125 ng/µl) 1 µl 0.5 µl 
 
Cycling parameters: 
Loop 1st 2nd 3rd 
Temperature 95 °C 95 °C 55 °C 65 °C 4 °C 
Time 1 min 1 min 1 min 2 min/1kb of 
plasmid 
2 min 
Cycle X1 X25 X1 
 
3.1.5.3 Dpn I digestion of the amplification products 
 
The Dpn I endonuclease (target sequence: 5´-Gm6ATC-3´) is specific for 
methylated and hemimethylated DNA. DNA isolated from almost all 
Escherichia coli strains is dam methylated. So it was used to specifically 
digest the parental (wild type) DNA template. After PCR, 1 µl diluted Dpn I (1 
µg/µl, 1:10) was added into the reaction tube and incubated at 37 °C for 1 
hour. 
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3.1.5.4 Transformation of mutated plasmids into XL-10 ultra competent 
cell 
 
In this step, the Dpn I treated reaction mixture was transformed into 
XL10-Gold® ultra competent cells. The nicked mutated plasmids would be 
repaired in vivo. The transformation was performed according to the 
manufacturer’s instructions.  
 
3.1.6  DNA gel electrophoresis 
 
DNA gel electrophoresis was used to check the results of restriction enzyme 
digestions, PCR reactions and DNA purification. Fragments of between 400 
bp and 12 Kbp were separated by using 0.5% agarose gels. The gels were 
stained with ethidium bromide (EB) at a concentration of 0.5 µg/ml and the 
DNA was visualized under UV light (365 nm). DNA fragments less than 400 
bp were separated on 1% or 1.5% agarose gels.  
 
3.1.7 Purification of DNA fragments from agarose 
 
In order to obtain single DNA fragments from digested plasmids, gel 
electrophoresis was performed at first. After that, the QIAquick Gel Extraction 
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kit was used to extract the DNA from the gel. The band of interest was 
immediately excised from the gel and the weight of the gel slice was 
determined. Three volumes solubilisation buffer (components not given in Kit) 
from the kit were added into the sample tube. The tube was incubated and 
vortexed at 50 °C for 10 minutes or longer until the agarose was completely 
dissolved. The solution was loaded onto the ion–exchange column by 
centrifugation at 12000 g for one minute. 500 µl solubilisation buffer was 
added to wash the column that was centrifuged at 12000g for one minute 
again. Three volumes high salt ethanol wash buffer were used for washing 
the column. Elution of the DNA from the column was carried out by adding 50 
µl of 10 mM Tris-HCl, pH8.5 or H2O on the column, which was centrifuged at 
12000g for one minute. To increase the DNA concentration in the eluate, a 
centrifugation step under vacuum was performed. This procedure was also 
used for the purification of PCR products. 
 
3.1.8 Precipitation of DNA 
 
When the DNA fragment was used for sequencing or some enzymatic 
reaction, that was sensitive to residual salt, it was necessary to precipitate 
the DNA. The precipitation of DNA was achieved by adding 0.1 Vol 3 M KAc 
and 2.5 Vol 100% ethanol and incubated at –20 °C for 10 minutes. After 
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removal of the supernatant the pellet was washed with 70 % ethanol and 
air-dried.  
 
3.1.9  Cloning of DNA 
 
3.1.9.1 DNA ligation  
 
This procedure was performed to construct new plasmid by ligating the target 
DNA fragment with vector plasmid. The DNA ligation reaction was performed 
following the protocol for T4 DNA Ligase (Gibco, USA). 4 µl 5x Ligase 
Reaction Buffer (250 mM Tris-HCl (pH 7.6), 50 mM MgCl2, 5 mM ATP, 5 mM 
DTT, 25% PEG8000) from kit, 1 µl T4 DNA Ligase (1U/µl) and 3:1 (molar 
ratio) insert DNA: vector DNA were mixed together in a microcentrifuge tube. 
The tube was kept at room temperature for 2 to 4 hours or for 16 hours at 
16°C.  
 
3.1.9.2  Preparation of competent E.coli cell 
 
Highly competent E.coli are important for transforming ligation products. The 
preparation of competent cells was carried out according to the method 
published by Hanahan in1983. 1 µl stock E.coli. XL-1 Blue was incubated in 
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10 ml LB liquid medium with 125 µg/µl Tetacyclin overnight at 37 °C. 2 ml of 
the overnight culture were added into 200 ml LB liquid medium and incubated 
for 2 to 3 hours at 37 °C until the O.D. (595) was between 0.5 and 0.7. The 
cells were placed on ice for 10 minutes. Then the cells were pelleted at 3000 
rpm for 5 minutes at 4 °C. The pellet was resuspended in 30 ml ice-cold TFB 
I solution and kept on the ice for 10 minutes. The cells were centrifuged again 
and resuspended in 4 ml TFB II. 100 µl aliquots of the competent cells were 
stored at –80 °C. 
 
3.1.9.3  Transformation of plasmid DNA into competent E.coli. cells 
 
10 to 100 ng supercoiled DNA or 4 µl of ligation reaction product were mixed 
with 100 µl competent E.coli. cells. This mixture was incubated on ice for 30 
minutes then heat-shocked by rapidly transferring it to a water bath 
preheated to 42 °C for 90 seconds and immediately placing it back on ice for 
two minutes. 900 µl LB medium was added to the mixture and incubated at 
37 °C for 40 minutes. The cells were pelleted and resuspended in 100 µl LB 
medium. The resuspended cells were spread on LB plates with the 
appropriate antibiotic selection. The plates were incubated for 16 to 20 hours 
at 37 °C after which individual colonies became visible.  
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3.1.10  DNA sequencing 
 
DNA sequencing was performed by the automated sequencing way using 
DNA molecular labeled with fluorescent dyes developed by Smith et al., 1986. 
After running the sequencing PCR reaction, the product was precipitated and 
dissolved in 20 µl H2O. 10 µl of the product was analyzed on the sequencing 
machine (ABI PRISM 310 Genetic Analyzer, PE). The DNA sequences were 
analyzed using the MacVector software or web-based tools 
(www.ncbi.nlm.nih.gov).  
 
3.2  Protein chemistry and biochemistry 
 
3.2.1  Preparation of mammalian cell lysates 
 
In order to analyze target protein expression in mammalian cells, cells were 
lyzed in RIPA buffer. Transfected cells were washed with PBS two times at 
room temperature, then Trypsin/EDTA was added and incubated with at 37 
°C until the adherent cells were detached. DMEM medium with fetal calf 
serum was added to inhibit the activity of Trypsin. The cells were transferred 
to a fresh 15 ml tube and centrifuged at 750 rpm for 5 minutes. Ice-cold PBS 
was added to wash the cell pellet two times. 0.6 ml of RIPA buffer was added 
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to resuspend the cell pellet. The resuspended cells were transferred to a 
fresh microcentrifuge tube and incubated on ice for 30 minutes. The sample 
was votexed for 30 seconds every 10 minutes. Then the solution was 
centrifuged at 10,000 g for 10 minutes at 4 °C. The supernatant fluid was the 
total cell lysate. The supernatant was transferred to a new microcentrifuge 
tube. 
 
3.2.2  Electrophoretic separation of proteins by SDS-PAGE 
 
Pre-cast one-dimensional denaturing NuPAGE Novex 4-12% Bis-Tris gels 
were obtained from Life Technologies. Protein samples were solubilised by 
boiling in the presence of Laemmli buffer (2x). An aliquot of the sample was 
loaded on the gel. Electrophoresis was performed at constant 200 V in a cold 
room. The gel front was allowed to migrate out of the gel before 
electrophoresis was stopped. Commercial protein standards enabled the 
estimation of apparent molecular weights.  
 
3.2.3 Protein blotting 
 
Protein transfer from Bis-Tris gel to Hybond-ECL Nitro-Cellulose membrane 
was carried out by electroblotting in a semi-dry electroblotter as described by 
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the manufacturer (Invitrogen, USA). The protein transfer process lasted 1 to 
2 hours at a constant current of 120 mA/64 cm2. After transfer, the protein 
standards should be clearly visible on the membrane.  
 
3.2.4 Immunodetection (Western blotting) 
 
The procedure was performed according to the protocol from Santa Cruz 
Biotechnology. Briefly, the membrane was blocked against non-specific 
binding by incubating the membrane in freshly prepared 0.5% TBS/Milk for 1 
hour at room temperature or overnight at 4 °C. The membrane was washed 
in TBS two times and incubated with primary antibody diluted at 1:1000 in 0.5 
% TBS/Milk for 1 hour at room temperature. The membrane was washed in 
TBS and incubated with the 2nd antibody-HRP (horseradish peroxidase) 
conjugate at room temperature for one hour. After this, the membrane was 
washed three times for 15 minutes at room temperature to remove excess 
2nd antibody conjugate. The specific protein bands were detected using 
chemiluminescence (ECL kit, Amersham-Pharmacia, UK) staining for 1 
minute. Membranes with cheminluminescence reagent were sealed in plastic 
and exposed to X-ray films for 1 to 30 minutes. 
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3.3 Detection of protein-protein interaction in the Yeast two-hybrid 
system 
 
The yeast two hybrid system used in this work was a GAL4 based two-hybrid 
system (Clontech, USA) that provided a transcriptional assay for detecting 
protein-protein interaction in vivo in yeast. The principle of this method is 
shown in the diagram below (Fig. 3.1). A bait protein (protein X) was 
expressed as a fusion to the GAL4 DNA-binding domain (GAL4 BD) and the 
putative interacting protein (protein Y) was expressed as a fusion to the 
GAL4 activation domain (GAL4 AD). When bait and its interacting protein 
were binding, the DNA-BD and AD were brought into proximity, thus 
activating transcription of reporter genes. This method can be used to identify 
novel protein interactions, confirm suspected interactions, and define 
interacting domains.  
 
 
Fig. 3.1 Yeast two-hybrid protein-protein interaction model  
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3.3.1 Preparation of competent yeast cell 
 
Competent yeast cells were used for the transformation of two plasmid DNA 
encoding the two interaction proteins. The process of making competent cells 
was mainly carried out of Yeast Handbook from Clontech Laboratories.Inc. 
Several fresh CG1945 colonies (one to three weeks old, 2–3 mm in diameter) 
were suspended in 1 ml of YPD or SD medium. The resuspended cells were 
incubated in 50 ml of YPD or the appropriate SD medium at 30 °C overnight 
for 16–18 hours with shaking at 250 rpm until stationary phase was reached 
(OD600>1.5). This overnight culture was transferred to a flask containing 300 
ml of YPD and incubated at 30 °C for about 3 hours with shaking (230 rpm) 
until the OD600 reached 0.4–0.6. The cells were collected and washed with 
H2O. 5 ml sterile 1X TE/1X LiAc buffer were used to suspend the cells. 100 µl 
cells were aliquotted into 1.5 ml microcentrifugation tubes and stored at –80 
°C. 
 
3.3.2 Transformation of plasmids into competent yeast cell 
 
0.1 µg of plasmid DNA and 100 µg of herring testes carrier DNA were mixed 
and added to a tube with 100 µl of yeast competent cells. Then 0.6 ml of 
sterile PEG/LiAc solution was added and vortexed at high speed for 10 sec to 
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completely mix all components. The tubes were incubated at 30 °C for 30 
min with shaking at 200 rpm. 70 µl of DMSO was added and mixed well by 
gentle inversion. A heat shock was performed at 42 °C water bath for 15 
minutes after which the tubes were placed on ice for 1 to 2 minutes. Cell 
pellets were obtained by a centrifugation at room temperature. The pellet 
was resuspended in 100 µl of sterile 1X TE buffer. These cells were spread 
on SD agar plates and the plates were incubated at 30 °C until colonies 
appeared (generally, 2 to 4 days). 
 
3.3.3 Detection of protein-protein interaction in yeast 
 
To test for interaction between two proteins, the bait and prey protein 
expressing plasmids (see 3.3) were co-transformed into competent yeast 
cells and the cells were plated on SD plates lacking the transformation 
markers for each of the two plasmids (usually tryptophan for the bait and 
leucine for the prey plasmid). Then the double transformants were streaked 
out on plates lacking histidine, tryptophan and leucine (-H,-L,-W) and 
incubated at 30 °C for 2 to 4 days. Colony growth on -H,-L,-W plates 
indicated activation of the HIS 3 reporter gene, which is a consequence of 
the physical interaction between bait and prey protein. 
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3.4  Cell biology 
 
3.4.1 General cell culture techniques 
 
All mammalian cell lines (NIH3T3 and HEK 293T) were cultured in a 
humidified incubator (Heraeus CO2-AUTO-ZEKO) at 37 °C with 5% CO2. 
Cell culture work was done in an airflow hood (BDK Luft-and 
Reinraumtechnik GMBH). All materials used in the laminar-flow hood were 
sterilized by treating the surface with 70% ethanol or UV light for 15 minutes. 
Cells were kept in DMEM medium with 5% FCS and 1% Penicillin/ 
Streptomycin (10.000 U/ml Penicillin and 10 mg/ml Streptomycin). Cell line 
stocks were frozen in liquid nitrogen in freezing medium (10% DMSO and 
90% FCS).  
 
3.4.2 Transient transfection of mammalian cells with plasmids 
 
Two different methods of introducing plasmid DNA into mammalian cells 
(calcium phosphate precipitation or liposome mediated transfection) were 
used in this work. The calcium phosphate method was carried out as 
described by Jordan et al. (1996). But since the transfection efficiency was 
not high with in this method, the liposomal transfection reagent Roti-fect 
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(Roth, Germany) was used in the experiments. The procedure was carried 
out according to the manufacturer’s description with some minor 
modifications. The ratio of plasmid DNA (weight in microgram) and liposome 
reagent (volume in micro liter) was between 1 to 1 or 1 to 2 depending on the 
particular plasmid and cell type. The tissue culture plates (1 million cells per 
35 mm plate) were prepared one day before the transfection. The incubation 
time of plasmid DNA/liposome mixture with the cells was about 6 hours at 37 
°C with 5% CO2 after which time fresh medium was added to the plates. Two 
days after transfection, the cells were harvested by different ways depending 
on the exact experiments. The transfection efficiency was assessed by using 
a parallel transfection with the pECFP C1 or pEYFP N1 plasmid, which 
usually showed around 90% transfection efficiency. But the transfection 
efficiencies of pECFP C1 ETV6, pEYFP N1 TIP60β and pEYFP N1 PIN1 
were much lower than the vector control about 40%, 10% and 40%, 
respectively. 
 
3.4.3 Protein-protein co-localization in mammalian cells 
 
To perform in vivo and in situ protein (co) localization, fluorescent protein 
tagged proteins were expressed in NIH3T3 mouse fibroblast cells using 
transient transfection. For colocalization studies, cyan and yellow fluorescent 
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proteins were used as tags because there is minimal spectral overlap 
between the emission and excitation spectra of these two proteins at the 
excitation and emission wavelength used in our microscope set-up. The cells 
were plated on glass cover slips. The method of transfecting plasmid DNA 
into mammalian cells was carried out as described above. Two days after 
transfection, cells were washed two times with PBS. Then the cells were 
fixed with freshly prepared 3.7% formalin/PBS for 15 minutes at room 
temperature. The cells were washed with PBS two times. Then 1% 
Triton-X100 was added for 15 minutes. Then the cells were washed again 
two times with PBS. Cover slips were put on the microscope slides and 
sealed at the edges by rubber cement. Protein co-localization was observed 
with a fluorescence microscope (Karl Zeiss, Germany) with filter 
combinations for cyan (475 nm emission maximum) and yellow fluorescent 
protein (527 nm emission maximum). The Openlab software package was 
used to control the CCD camera, and take digital photos of observed cells as 
well as to perform volume deconvolution on image stacks. Cells transfected 
with only one plasmid (CFP or YFP alone) were used as controls. 
 
3.4.4 Cell cycle analysis 
 
It is known that PIN1 plays an important role in cell cycle regulation. We 
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therefore decided to investigate whether the expression of ETV6, PIN1 or 
TIP60 as well as the coexpression of ETV6 with PIN1 and ETV6 with TIP60 
would have an effect on the cell cycle of HEK293T cells. The transfection 
procedure was carried out as described in Methods (chapter 3.4.2). As 
negative control, mock transfected cells were used. These cells were plated 
at the same density and treated the same way as the experimental cells 
except that no DNA was added in the transfection step. The cells were 
harvested 48 hours after transfection and stained with 5 µg/ml Hoechst 334 
dye and 50 µg/ml propidium iodide. The cells were analyzed by FACS. The 
DNA contents of the cells were measured using the Hoechst stain. The PI 
stain was used to exclude dead cells (PI positive cells). To analyze the DNA 
contents of the transfected cells, cells were gated for GFP, YFP or GFP/YFP 
positivity.  
 
3.5  Reporter gene assays 
 
3.5.1  Reporter plasmids 
 
Two different reporter systems were used in this work. One for analyzing the 
transcriptional properties of proteins and protein domains were fused to a 
GAL4 DNA binding domain. Here the reporter plasmid pGAL4 TK Luc which 
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contains 5 GAL4 DBD binding sites and a TK (Herpes simplex virus 
thymidine kinase) minimal promoter followed by the firefly luciferase reporter 
gene, was used. This plasmid has a medium to high expression level of firefly 
luciferase and was used to study transcriptional repression. The other 
reporter gene system was based on the ETV6 responsive stromelysin-1 
promoter. Two reporter plasmid, were used in this system: pTR334 and 
pTR89. pTR334 had a 334 bp fragment of the rat stromelysin-1 promoter, 
which contains an ETV6 (EBS) and two ets potential binding sites (TBS), 
upstream of the firefly luciferase gene. pTR 89 was used as a control plasmid. 
It has only 89 bp of the rat stromelysin-1 promoter without EBS and TBS. 
Both pTR 334 and pTR 89 were obtained from Prof. Hiebert, Nashville, Ten. 
To control for transfection efficiency the phRL-null plasmid, which encodes 
the Renilla luciferase under the control of a minimal promoter, was used. 
A.                                          B. 
            p TK Luc                                p TR 334                            
 
C.                                           
 p TR 89 
Fig. 3.2  Reporter plasmids used in reporter gene assays 
 
In order to analyze the significance of protein-protein interactions on the 
UAS    TK     Luciferase EBS   TBS     Luciferase 
-334 rat stromelysin-1 
Luciferase 
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transcriptional activity of ETV6, reportergene assays were performed in 
which ETV6 or its mutants were cotransfected with TIP60 or PIN1 in HEK 
293 T cells. About 2.1 µg of total plasmid DNA was used for 5x105 cells in a 
single well of a 24 well tissue culture dish. The transfection was carried out 
as described above. In some experiments, the histone deacetyltransferase 
(HDAC) inhibitor TSA was added 24 hours after transfection at a 
concentration of 75 nM. After 48 hours, the transfected cells were washed 
two times with PBS. 100 µl of passive lysis buffer (PLB) (Dual-Luciferase® 
Reporter Kit, Promega) was added into each well to lyse the cells. The total 
cell lysate was centrifuged for 1 minute at 4 °C at 12000 g. 20 µl of 
supernatant was mixed with 100 µl LAR II substrate for 3 seconds and the 
firefly luciferase activity was measured for 10 seconds in a luminometer 
(TURNER DESIGN, Germany). Then 100 µl of stop & Glo reagent (this 
solution stops the firefly luciferase reaction and initiates the Renilla luciferase 
reaction) was mixed with the solution and the Renilla luciferase activity was 
measured for 10 seconds.  
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4. Results 
 
4.1  Plasmid constructs 
 
4.1.1  Cloning of TIP60β and PIN1 cDNA 
 
The cDNA of TIP60β identified as prey of ETV6 in the yeast two-hybrid 
screen of a HeLa cDNA library lacked the first 5 codons. In addition, it 
contained several hundred base pairs of 3’ UTR (untranslated region). Using 
this original TIP60β cDNA cloned into the pEGFP-C1 and pDS-Red-C1 
vectors, we did not observe a fluorescence signal in transiently transfected 
293T and NIH3T3 cells. We hypothesized that this could be due to the long 3’ 
UTR sequence. The situation for the original PIN1 prey clone was similar: It 
did not contain the codons for the first 6 amino acids and had a long 3’UTR 
as well. The pEGFP-C1-PIN1 contstruct showed poor expression in transient 
transfection experiments as well. The complete cDNA of TIP60β and PIN1 
were generated by PCR amplification using linker-adaptor primers 
(TIP60ATGXhol and TIP60B1765EcoRI; PIN1ATGXhol and PIN1B498 EcoRI) 
from the original Y2H clone (pGAD-GH vector). The primers also contained 
the sequences coding for the first 5 amino acids of TIP60β and the first 6 
amino acids of PIN1 and a Kozak consensus site. The PCR fragments were 
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cloned into the EcoRI (5’ site) and Sal1 (3’ site) of the pEYFP-N1 vector. The 
3’ primers were designed so that the YFP coding sequence of pEYFP-N1 
would be in frame with TIP60β and PIN1. The expression of the fusion 
proteins TIP60β and PIN1 with YFP were observed using fluorescence 
microscopy after transient transfection experiments (Fig. 4.1). The proteins 
were also detected in Western blot experiments. (Fig. 4.2). 
 
 
Fig. 4.1  Expression TIP60β-YFP and PIN1-YFP fusion proteins in mammalian cells. 2 
µg of pEYFP N1 TIP60β or pEYFP N1 PIN1 plasmid DNA was transfected into 2 x 106 
mouse NIH3T3 cells. The transfected cells were fixed after 48 hours and observed with a 
fluorescence microscope. The picture was taken with an excitation and emission filter set, 
which is specific for YFP (yellow fluorescent protein). The pictures were taken by a CCD 
camera controlled by Openlab software. The left picture shows the TIP60β-YFP protein in 
the nucleus of a transfected cell. The right picture shows that the PIN1-YFP protein is 
localized to both nucleus and cytoplasm. The pictures were acquired as grey scale 
images by the CCD camera and pseudo-colored in OpenLab to reflect the color of the two 
fluorescences as seen through the microscope. 
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Fig. 4.2  TIP60β and PIN1 protein expression in mammalian cell. 2 µg of pEYFP N1 
TIP60β or pEYFP N1 PIN1 were transfected into 2 x 106 human 293T cells. The cells were 
lysated with RIPA buffer. 10% of the cell lysate was loaded on a 10% PAGE gel and 
transferred to a nitrocellular membrane after electrophoresis. Rabbit Anti-GFP or 
anti-PIN1 antibodies were used as primary antibodies. The secondary AB was 
anti-rabbit-HRP. Plasmids used for transfection are shown below the lanes. The 
expression CFP-ETV6 was used as a positive control for the anti-GFP antibody, lane 4 
shows a weak TIP60β-YFP band. Lane 5 and lane 6 show the PIN1-YFP bands, which 
serve as the positive control for the anti-PIN1 antibody. Lane 8 and 9 show the PIN1-YFP 
(upper) and native PIN1 (lower) bands. 
1 2 3 4 5 6 7 8 9 10 
293T 
C
FP-ETV6 
C
FP-ETV6 
TIP60β-YFP 
PIN
1-YFP 
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Protein standrad 
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293T 
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4.1.2  Deletion mutants of ETV6 
 
To map the PIN1 and TIP60β interaction domains of ETV6 two deletion 
mutants of ETV6 were constructed in the yeast expression vector pGBT9. 
From this vector, proteins are expressed as fusions with the GAL4-DNA 
binding domain. The deletion mutant ETV6(314-342) interacted with both 
TIP60β and PIN1. However, ETV6(314-342) was found to have a one base 
pair deletion at aa 337 which caused a frame shift in the remaining 5 amino 
acids. To clarify whether PIN1 and TIP60β interact with the sequence 
between aa 314 and 336 of ETV6 or the frame shifted sequence from aa 337 
to 342, two new constructs were made: one expressing ETV6 aa 314 to 336 
and the other expressing ETV6 aa 314 to 342 (without frame shift). So the 
DNA sequences encoding ETV6 amino acids 314-336 and 314-342 were 
amplified by PCR with linker adaptor primers containing an EcoRI restiction 
enzyme site in the forward primer and a SalI restriction enzyme site in the 
backward primered by following a stop codon (Tel 964 Eco-T, ETV6 1032B 
SAL1, ETV6 1047B SAL1). The PCR products were cloned into the EcoRI 
and SalI site of pGBT9. The sequence of these constructs was verified by 
sequencing across the cloning sites. 
4.1.3  Site-directed mutagenesis of ETV6 and TIP60β 
 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
91 
The conserved amino acids Gly (aa 380) and Leu (aa 385) in the acetyl 
co-enzyme A binding site of TIP60β were changed into aspartic acid and 
serine, respectively, by site-directed mutagenesis (A of Table 4.1). The 
resulting TIP60β-DRS mutant has no acetyltransferase activity (HAT dead 
mutant) (Gavaravarapu and Kamine, 2000).  
 
It was shown that ETV6 is phosphorylated by the p38 kinase at Ser257 (Arai 
et al., 2002). We found that ETV6 has two potential PIN1 interaction domains: 
one in the pointed domain, the other in the central domain of ETV6. It is 
known that PIN1 interacts specifically with Ser-Pro or Thr-Pro sites which are 
phosphorylated at the serine or threonine. In B of table 4.1, those S-P or T-P 
motifs in ETV6 that are potential PIN1 binding motifs are underlined. We 
chose to mutate the serines at positions 106, 257 and 332, which were the 
most likely targets for PIN1 binding, into alanines. Alanines can not be 
phosphorylated. The introduced mutations were confirmed by sequencing. 
The mutated constructs are summarized in table 4.1. 
 
Table 4.1 Mutated constructs of ETV6 and TIP60β  
 
A. 
Point mutations in the conserved acetyltransferase motif of the TIP60  
  
                Acetyl Co-enzyme A binding site 
TIP60α        YNVACILTLPPYQRRGYRKLLIEF 
TIP60β DRS   YNVACILTLPPYQRRDYRKLSIEF 
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B. 
 
 
C. 
 Source plasmids Insert Mutated sites Name of mutant 
pECFP-C1-ETV6 ETV6 S106A pECFP-C1-ETV6(S106A) 
pECFP-C1-ETV6 ETV6 S257A pECFP-C1-ETV6(S257A) 
pECFP-C1-ETV6 ETV6 S323A pECFP-C1-ETV6(S323A) 
pM1- ETV6 ETV6 S323A pM1-ETV6(S323A) 
pEYFP-N1-TIP60β TIP60β G380D, L385S pEYFP-N1-TIP60β(DRS) 
pGAD-GH-TIP60β TIP60β G380D, L385S pGAD-GH-TIP60β(DRS) 
 
4.2  Interaction of ETV6 with TIP60β and PIN1  
 
The interaction between ETV6, its deletion mutants and TIP60β and its HAT 
domain mutants were performed in the yeast two-hybrid system. This method 
was also used for assaying the interaction between ETV6 (including the 
various deletion mutants of ETV6) and PIN1 and its various mutants. 
4.2.1  Interaction between ETV6 and TIP60β and the TIP60β HAT mutant 
 
In previous work in our group (performed by Jasmina Putnik and Michael 
Kickstein) the interaction between ETV6 and TIP60β had been analyzed in 
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some detail using the yeast two hybrid system. It was shown that the full 
length TIP60β is able to interact with full length ETV6, the central domain of 
ETV6(aa118-345) and the C-terminal portion of the central domain 
(aa282-345). Here these findings were extended to show that the 25 amino 
acids from 314 to 336 of ETV6 are sufficient for interaction with full length 
TIP60β (Fig. 4.3). 
 
Previously, we had also shown that deletion mutants of TIP60β were unable 
to interact with full length ETV6. However, these deletion mutants were able 
to interact with the C-terminal portions of the ETV6 central domain. In fact, 
we could show that the MYST domain zinc finger of TIP60β was sufficient for 
interaction with these C-terminal portions of the ETV6 central domain. To 
explain this remarkable interaction pattern between the ETV6 and TIP60β 
deletion mutants, we hypothesized that interaction between ETV6 and 
TIP60β was a two step process: In a first step a ETV6 might be acetylated by 
TIP60β which would result in a confirmational change of ETV6; then the zinc 
finger of the TIP60β MYST domain would be able to interact with an exposed 
interaction interface in the ETV6 central domain. To test this hypothesis, the 
TIP60β DRS mutant, which lacks acetyltransferase activity, was tested for 
interaction with ETV6 and several ETV6 deletion mutants in the yeast two 
hybrid systems. Interestingly, the TIP60β-DRS mutant was not able to 
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interact with full length ETV6 or with the central domain (aa118-345) of ETV6. 
However, the HAT deficient TIP60β mutant was still able to interact with the 
C-terminal half (aa219-345) and quarter (aa 282-345) of the the central 
domain of ETV6 (Fig 4.4). This is exactly the same interaction pattern which 
was seen with the TIP60β deletion mutants including the mutant containing 
only the TIP60β MYST domain zinc finger. These observations agree with 
what would be expected if the HAT activity of TIP60β is needed to change the 
conformation of ETV6 to allow efficient interaction. 
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Fig. 4.3  Mapping of the TIP60β interaction domain of ETV6. Yeast strain CG1945 was 
cotransformed with a pGBT9 plasmid expressing ETV6 or the indicated ETV6 mutants as 
a fusion protein with the GAL4-DBD and with pGAD-GH-TIP60β, which expressed TIP60β 
as a fusion protein with the activation domain of GAL4 (GAL4-AD). The plate on the left 
hand side lacks amino acids tryptophan and leucine and allows only growth of 
cotransformants. The plate on the right hand side which is also lacking the amino acid 
histidine only allows growth of cotransformants in which interaction between the 
GAL4-DBD and the GAL4-AD fusion proteins occurs. Clones no. 1, 4, 6, 8 and 9 show 
growth on the left hand plate indicating interaction between TIP60β and the following 
portions of ETV6: full length (no. 1), ETV6(118-345) (no. 4), ETV6(282-345) (no. 7), 
ETV6(314-341) (no. 8) and ETV(314-336) (no. 9). The plates were assayed after 4 days of 
incubation at 30°C.  
No. 
ETV6 or deletion mutant expressing 
plasmid 
TIP60β expressing 
plasmid 
Interaction 
 
1 pGBT9-ETV6 PGAD-GH-TIP60β + 
2 pGBT9-ETV6 (1-59) PGAD-GH-TIP60β - 
3 pGBT9-ETV6 (1-126) PGAD-GH-TIP60β - 
4 pGBT9-ETV6 (118-345) PGAD-GH-TIP60β + 
5 pGBT9-ETV6 (118-218) PGAD-GH-TIP60β - 
6 pGBT9-ETV6 (219-287) PGAD-GH-TIP60β - 
7 pGBT9-ETV6 (282-345) PGAD-GH-TIP60β + 
8 pGBT9-ETV6 (314-341) PGAD-GH-TIP60β + 
9 pGBT9-ETV6 (314-336) PGAD-GH-TIP60β + 
10 pGBT9-ETV6 (340-420) PGAD-GH-TIP60β - 
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Fig. 4.4  Interaction between ETV6 and the HAT deficient TIP60β mutant TIP60β DRS. 
The same cotransformation assay in yeast strain CG1945 as in Fig. 4.3 was performed. 
This time the HAT deficient TIP60β DRS mutant was expressed as fusion protein with the 
GAL4-AD. The left plate shows the transformation control and the right hand plate is the 
assay for protein-protein interaction. Interestingly, there is no interaction of the HAT 
deficient TIP60β protein with full length ETV6 or with the N-terminal of central domain of 
ETV6 (aa118-218). However, the HAT deficient TIP60β can still interact with the central 
domain of ETV6, C terminal half and the C-terminal quarter of the central domain (No. 2, 
No.4 and No. 6). The plates were assayed after 4 days of incubation at 30°C. 
 
4.2.2  Interaction between ETV6 and PIN1 
 
The yeast two-hybrid system was used as described above to analyze the 
No. ETV6 or deletion mutant expressing plasmid 
TIP60β-DRS expressing 
plasmid Interaction 
1 ETV6 pGAD-GH-TIP60βDRS - 
2 ETV6 (118-345) pGAD-GH-TIP60βDRS + 
3 ETV6 (118-218) pGAD-GH-TIP60βDRS - 
4 ETV6 (219-345) pGAD-GH-TIP60βDRS + 
5 ETV6 (219-287) pGAD-GH-TIP60βDRS - 
6 ETV6 (282-345) pGAD-GH-TIP60βDRS + 
7 ETV6 (314-341) pGAD-GH-TIP60βDRS - 
8 ETV6 (314-336) pGAD-GH-TIP60βDRS - 
-L-W-H  -L-W 
 1    8    
2          7 
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interaction between ETV6 and PIN1. Full length PIN1 interacted with full 
length ETV6, the N terminus of ETV6 (ETV6(1-59), ETV6(1-126)), and the 
central area of ETV6, ETV6(219-345) and ETV6(282-345). The WW domain 
of PIN1 interacted with the isolated N-terminal and C-terminal halves of 
central domain of ETV6, ETV6(118-218) and ETV6(219-345) but not with the 
complete central domain (118-345). The PPIase domain of PIN1 showed 
interaction with the C-terminal half (219-345) and the C-terminal quarter 
(282-345) of the central domain of ETV6 (Fig. 4.5). These results implied that 
there might be two potential binding sites for PIN1 on ETV6: one in the 
N-terminus of ETV6 including the pointed domain (aa1-126) and one in the 
C-terminal half of the central region (aa 282-345). The fact that the isolated 
WW domain is also interacting with the N-terminus of the central domain 
might be an artefact of the assay due to interaction of the WW domain with 
proline rich regions. Similar to the interaction pattern observed with ETV6 
and TIP60β, the isolated PIN1 domains are not able to interact with full length 
ETV6. This might be explained by conformational changes that are 
necessary for efficient interaction to occur for which both the WW and the 
PPIase domains of PIN1 are required. 
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+ denotes growth on plates lacking tryptophan, leucine, and histidine (SD, –W, -L, -H) 
 
Fig. 4.5  Analysis of ETV6 – PIN1 interaction. As in figures 4.3 and 4.4 yeast strain 
CG1945 was co-transformed with a plasmid expressing ETV6 or one of nine ETV6 
deletion mutants as a GAL4-DBD fusion protein and with a plasmid expressing full length 
PIN1, the WW domain of PIN1 or the PPIase domain of PIN1 as a fusion protein with the 
GAL4-AD. Interaction between the proteins was assayed by growth on SD plates lacking 
histidine, tryptophane and leucine. See text for description of results. The plates were 
assayed after 4 days of incubation at 30°C. 
 
4.3  Subcellular co-localization of ETV6 with TIP60β and PIN1 
 
4.3.1  Subcellular localization of ETV6, TIP60β and PIN1  
 
4.3.1.1  Subcellular localization of ETV6  
 
To examine the subcellular localization of ETV6, a CFP-ETV6 fusion protein 
No. 
GAL4-DBD 
Fusion 
GAL4-AD fusion 
PIN1 
GAL4-AD fusion 
PIN1 WWD 
GAL4-AD fusion 
PIN1 PPIase 
1 ETV6 +++ - - 
2 ETV6 (1-59) + - + 
3 ETV6 (58-126) - - - 
4 ETV6 (1-126) ++ - - 
5 ETV6 (118-345) - - - 
6 ETV6 (118-218) - ++ - 
7 ETV6 (219-345) ++ ++ ++ 
8 ETV6 (219-287) - - - 
9 ETV6 (282-345) ++ - ++ 
10 ETV6 (420-452) - - - 
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was expressed in mouse fibroblast cells (NIH3T3) after transient transfection. 
The transfected cells were observed with fluorescence microscopy (Zeiss). 
Both nuclear and cytoplasmic localization of CFP-ETV6 were observed with 
some cells exhibiting exclusively nuclear localization of CFP-ETV6 while 
others had both nuclear and cytoplasmic staining. There appeared to be 
some correlation between the expression level of the CFP-ETV6 fusion 
protein and its subcellular localization. In cells with moderate to low 
expression CFP-ETV6 was localized predominantly in the nucleus. The 
nuclear staining with CFP-ETV6 was finely granular and spared the nucleoli 
(Fig. 4.6A). When the CFP-ETV6 fusion protein was expressed at high levels, 
it would localize in the cytoplasm as well (Fig. 4.6A). It appeared as if there is 
a certain limit as to how much CFP-ETV6 can be accommodated in the 
nucleus. If that limit is exceeded any additional protein would remain in the 
cytoplasm of the cell. However, we do not have firm proof that the expression 
level of CFP-ETV6 is the only factor that determines its subcellular 
distribution. 
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A. 
     
 
B 
 
Fig. 4.6  Subcelluar localization of CFP-ETV6 in murine fibroblast cells. A: NIH3T3 cells 
were transiently transfected with a CFP-ETV6 expressing plasmid. The upper pictures 
were taken with a 400x objective with a filter combination to allow CFP visualization. The 
exposure time for the left picture is 1000 ms and shows most of the CFP-ETV6 protein 
localized in the nucleus. The middle picture has an exposure time of 400 ms and shows 
CFP-ETV6 with predominant nuclear localization. The right picture was taken at 150 ms 
exposure time and shows most of the CFP-ETV6 localized in the cytoplasm. There is still 
CFP-ETV6 in the nucleus but it cannot be seen very well at this short exposure time. 
Arrows point to CFP-ETV6 in nucleus. The pictures were acquired as grey scale images 
by the CCD camera and pseudo-colored in OpenLab to reflect the color of the two 
fluorescences as seen through the microscope. B: Distribution of transfected cells 
showing ETV6 in the nucleus only (N), more ETV6 in the nucleus than in the cytoplasm 
(N>C) and more ETV6 in the cytoplasm than in the nucleus (N<C). Approximately 100 
transfected cells were evaluated and counted.   
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4.3.1.2  Subcellular localization of TIP60β  
 
The subcellular localization of TIP60β was examined by expressing a TIP60β 
yellow fluorescent protein (YFP) fusion protein in NIH3T3 cells. In most cells, 
TIP60β-YFP was observed exclusively in the nucleus. Only in some cells 
with very high expression of TIP60β-YFP a small amount of TIP60β-YFP 
could be observed in the cytoplasm (Fig. 4.7).  
A. 
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B. 
 
Fig. 4.7  Subcelluar localization of TIP60β. A: NIH3T3 cells were transiently transfected 
with a plasmid expressing TIP60β-YFP. The pictures were taken with a 40x objective (final 
magnification about 400x) and an excitation and emission filter set for YFP fluorescence. 
The picture on the left side shows TIP60β-YFP in the nucleus. The picture on the right 
side shows some TIP60β-YFP in the cytoplasm in a cell with a high level of TIP60β-YFP 
expression (arrow points to TIP60β-YFP in the cytoplasm). The pictures were acquired as 
grey scale images by the CCD camera and pseudo-colored in OpenLab to reflect the color 
of the two fluorescences as seen through the microscope. B: Distribution of transfected 
cells showing TIP60β-YFP in the nucleus only (N) and cells with some TIP60β-YFP in the 
cytoplasm (N>C). Approximately 100 transfected cells were evaluated and counted. 
 
4.3.1.3  Subcellular localization of PIN1 
 
The subcellular localization of PIN1 was assayed in the same way as for 
ETV6 and TIP60β. An N-terminal PIN1-YFP fusion protein was expressed 
transiently in NIH3T3 cells. PIN1-YFP was always found in the nucleus of 
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transfected cells with most cells showing also some PIN1-YFP in the 
cytoplasm. The nuclear distribution of PIN1-YFP was diffuse with sparing of 
the nucleoli. In some nuclei foci of PIN1-YFP were observed (Fig. 4.8). There 
was some correlation with the amount of PIN1-YFP expression in a cell and 
its appearance in the cytoplasm (Fig. 4.8. C).  
A.                                          B. 
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Fig. 4.8  Subcelluar localization of PIN1. A: NIH3T3 cells were transiently transfected with 
a plasmid expressing PIN1-YFP. The pictures were taken with a 40x objective (final 
magnification about 400x) and an excitation and emission filter set for YFP fluorescence.  
The picture on the left hand side shows PIN1-YFP in the nucleus and cytoplasm. These 
cells have a rather high level of PIN1-YFP expression. B: The picture on the right side 
shows a cell with almost exclusive nuclear distribution of PIN1-YFP. Nuclear foci of 
PIN1-YFP can be observed in this cell. The pictures were acquired as grey scale images 
by the CCD camera and pseudo-colored in OpenLab to reflect the color of the two 
fluorescences as seen through the microscope. C: Distribution of transfected cells 
showing PIN1 in the nucleus only (N) and cells with some PIN1 in the cytoplasm (N>C). 
Approximately 100 transfected cells were evaluated and counted. 
 
4.3.2  Co-localization of ETV6 with TIP60β and PIN1 
 
4.3.2.1  Co-localization of ETV6 and TIP60β 
 
To further confirm the interaction between ETV6 and TIP60β, colocalization 
experiments with fluorescent protein tagged ETV6 and TIP60β were carried 
out using transient transfection in murine fibroblast cells. CFP and YFP as 
described above were used as tags for ETV6 and TIP60β, respectively. 
These colors were chosen for the colocalization experiments because there 
is no spectral overlap between these colors with the excitation and emission 
filter sets available for these colors on our microscope. These experiments 
showed that CFP-ETV6 and TIP60β-YFP have comparable distribution in the 
nucleus (Fig. 4.9, left column). Also, in cells with high levels of CFP-ETV6 
expression and predominant cytoplasmatic localization of CFP-ETV6 there 
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was still colocalization of CFP-ETV6 and TIP60β-YFP in the nucleus (Fig. 4.9 
middle and right column). These observed colocalizations are in agreement 
with the data from the yeast two hybrid experiments (Fig. 4.3) and the 
GST-pull-down experiment (Putnik, Ph.D. thesis, 2001). To examine the 
colocalization of ETV6 and TIP60β in the nucleus in more detail, volume 
deconvolution of Z-stack images (Z spacing 0.2 µm) taken from 
co-transfected cells was performed. Deconvolution is a mathematical 
operation that allows the partial removal of light from out-of focus objects, 
resulting in images that resemble those obtained with a confocal microscope. 
In figure 4.10 the results of such a deconvolution performed separately for 
the CFP and YFP channel from a single cell are shown. It can be clearly seen 
that the CFP-ETV6 pattern matches almost exactly that of TIP60β-YFP.  
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Fig. 4.9  Co-localization of ETV6 and TIP60β in NIH3T3 cells. NIH3T3 cells were 
transiently co-transfected with plasmids expressing CFP-ETV6 and TIP60β-YFP. The 
pictures were taken with a 100x objective (final magnification about 1000x). Three 
different cells are shown (left, middle and right column). The pictures in the upper row 
were taken with an excitation and emission filter set for CFP fluorescence and the pictures 
in the middle row were taken with an excitation and emission filter set for YFP 
fluorescence. The third row shows an overlay of the images from the CFP (blue) and YFP 
(yellow) images. The pictures were acquired as grey scale images by the CCD camera 
and pseudo-colored in OpenLab to reflect the color of the two fluorescences as seen 
through the microscope. 
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Fig. 4.10  Deconvoluted images of the CFP (left side) and the YFP (right side) channel 
from a section through an NIH 3T3 cell nucleus contransfected with CFP-ETV6 and 
TIP60β-YFP expressing plasmids. The images were taken with a 100x objective. It is quite 
evident that the pattern of nuclear CFP-ETV6 and TIP60β-YFP distribution is almost 
identical. Arrows point to three prominent bright spots, which are seen in both 
fluoresecence channels.  
 
4.3.2.2  Coexpression of TIP60β affects subcellular localization of ETV6 
 
When we performed the colocalization studies of ETV6 and TIP60β, we 
noticed that the co-expression of TIP60β seemed to influence the distribution 
of ETV6 in the same cell. To examine this phenomenon on a 
semi-quantitative basis, we varied the ratio of CFP-ETV6 to TIP60β-YFP 
 
CFP- ETV6 (CFP channel)               TIP60β -YFP (YFP channel) 
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expressing plasmids in three different co-transfections and analyzed the 
nuclear and cytoplasmic distribution of CFP-ETV6 and TIP60β-YFP. We used 
the following ratios of CFP-ETV6 to TIP60β-YFP: 3:1, 1:1, 1:7. While the 
relative distribution of cells expressing TIP60β-YFP in the nucleus only (N) to 
those cells expressing TIP60β-YFP in the nucleus and less in the cytoplasm 
(N>C) did not change in the different experiments, there was a marked 
change in the distribution of CFP-ETV6 with a shift towards more cells 
showing only nuclear localization of CFP-ETV6 the more TIP60β-YFP was 
used in the transfection experiment (Fig 4.11). This implies that TIP60β is 
able to influence the subcellular localization of ETV6.  
 
 
 N (Nucleus)  N>C (Cytoplasm)  C >N 
No. 1 2 3 4 5 6 7 8 9 10 11 
CFP-ETV6 3 1 1 0 3 1 1 0 3 1 1 
TIP60β-YFP 1 1 7 0 1 1 7 0 1 1 7 
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Fig. 4.11  TIP60β-YFP affects the subcellular localization of CFP-ETV6. The pECFP- 
C1-ETV6 plasmid and the pEYFP-N1-TIP60β plasmids were cotransfected at different 
ratios (3:1, 1:1 and 1:7) into NIH3T3 cells. It can be seen that there is a shift towards more 
nuclear localization of CFP-ETV6 as the amount of TIP60β-YFP expressing plasmid 
increases. About 100 cells co-expressing both fusion proteins were counted in each 
experiment. Percentages for CFP-ETV6 are represented as blue bars, percentages for 
TIP60β-YFP are shown as green bars. 
 
 
4.3.2.3  Co-localization of ETV6 and PIN1 
 
To examine whether ETV6 would colocalize with PIN1, the plasmids 
pECFP-C1-ETV6 and pEYFP-N1-PIN1 were co-transfected into NIH3T3 
cells. As can be seen in figure 4.12 both proteins show a very similar nuclear 
distribution pattern. In addition, PIN1-YFP is found in the cytoplasm in more 
than 80% of the cells examined. The similarity of the nuclear distribution of 
CFP-ETV6 and PIN1-YFP strongly suggests that both proteins physically 
interact in vivo. 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
111 
A. 
 
 
B. 
 
 
 
Fig. 4.12  Co-localization of ETV6 and PIN1 in NIH3T3 cells. A: NIH3T3 cells were 
transiently co-transfected with plasmids expressing CFP-ETV6 and PIN1-YFP. The 
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pictures were taken with a 63x objective (final magnification about 630x). The left image 
was taken with an excitation and emission filter set for CFP fluorescence and the the 
middle image was taken with an excitation and emission filter set for YFP fluorescence. 
The right image shows an overlay of the CFP (blue) and YFP (yellow) images. CFP-ETV6 
and PIN1-YFP colocalize in nucleus where both proteins show a very similar pattern of 
bright speckles. B: Diagram showing distribution of the relative nuclear (N) and 
cytoplasmatic distribution of CFP-ETV6 and YFP-PIN1 in this experiment. CFP-ETV6 was 
found only in the nucleus in 88% of the cells, while in more than 80% of the cells 
YFP-PIN1 could be observed in both nucleus and to a lesser extent in the cytoplasm. 
Percentages for CFP-ETV6 are represented as blue bars, percentages for PIN1-YFP are 
shown as green bars. 
 
4.3.3  Effect of TIP60β and PIN1 on the function of ETV6 
 
4.3.3.1  ETV6 is a transcriptional repressor  
 
It is known that ETV6 acts as a strong transcriptional repressor when 
assayed in various reporter gene systems. We therefore wanted to examine 
whether the observed protein interactions of ETV6 with TIP60β and PIN1 
would affect the repression function of ETV6. The repression function of 
ETV6 was assayed using two different reporter gene systems.  
 
In the first system, ETV6 and various deletion mutants of ETV6 were 
expressed as a fusion proteins with a heterologous DNA binding domain, the 
DNA binding domain of the yeast transcription factor GAL4 (GAL4-DBD). In 
this system the reporter plasmid contained the firefly luciferase gene under 
the control of part of the Herpes Simplex Virus thymidine kinase promoter 
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and five upstream activating sequences (UAS) which are binding sites for the 
GAL4-DBD (GAL4(5)-tk-Luc) (Fig. 3.2A). The tk-promoter of this reporter 
plasmid will direct expression of moderate levels of luciferase if transfected 
into mammalian cells. 
 
In the second system, ETV6 was expressed as a fusion protein with the cyan 
fluorescent protein. As a reporter plasmid construct expressing the firefly 
luciferase gene under the control of the ETV6-responsive stromelysin-1 
promoter was used (pTR344). pTR334 contains 344 base pairs of the 
stromelysin-1 promoter including an ets binding site (EBS) and two ets 
potential binding sites (TBS). As a control reporter plasmid, a contstruct 
containing a truncated stromelysin-1 promoter without the EBS and TBS was 
used (pTR89). In this system the effect of ETV6 on the transcription of the 
reporter gene was dependent on the function of the native DNA binding 
domain of ETV6 (Fig. 3.2B). 
 
To demonstrate that ETV6 mediated transcriptional repression was 
dependent on the function of histone deacetylases, trichostatin-A, an inhibitor 
of HDACs, was added 24 hours after transfection at a concentration of 75 nM 
to the cells. All experiments were performed at least in triplicate. A plasmid 
containing the Renilla luciferase gene (Fig. 3.2C) with a minimal promoter 
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was cotransfected as a transfection control. Firefly luciferase values were 
normalized to the Renilla luciferase values. 
 
As can be seen in Fig 4.13, a GAL4DBD-ETV6 fusion protein mediates 
strong repression of the luciferase expression (18 fold). The C-terminal 
region of the central ETV6 domain which had been shown to interact with 
TIP60β still mediates about a two-fold repression of luciferase expression. 
 
Using the stromelysin-1 promoter based reporter plasmids about four-fold 
repression could be achieved when using 0.3µg of pECFP-C1-ETV6 plasmid. 
A good expression and repression (3.7 fold) of the firefly luciferase gene was 
evident from the pTR344 plasmid (bars 1 and 2). The serine to alanine 
mutants at position 106 and 257 of ETV6 showed slightly higher repression 
(6.2 fold and 7.8 fold) than ETV6. The ETV6(S332A) mutant had a similar 
repression ability like wild type ETV6 (Fig. 4.14). 
 
Addition of TSA to the medium led to a partial relieve of the transcriptional 
repression mediated by GAL4DBD-ETV6 (Fig 4.15 compare bars 1 to 4). 
This effect has been described before (Chakrabarti and Nucifora, 1999; 
Lopez et al., 1999). However, the transcriptional repression mediated by 
GAL4DBD-ETV6(282-345) could be completely abolished by the addition of 
TSA (compare bars 2 and 5 in Fig. 4.15). This is the TIP60β interaction 
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domain of ETV6. These findings can be interpreted in the following way: 
transcriptional repression by ETV6 is mediated through a HDAC dependent 
and a HDAC independent pathway. The repression mediated through amino 
acids 282-345 of ETV6 is completely dependent on HDAC function. 
 
 
 
 
 
 
Plasmid 1 2 3 
pTK Luc + + + 
pM1 ETV6  +  
pM1 ETV6 
(282-345) 
  + 
                                     
Fig. 4.13  GAL4(5)-tk-Luc based reporter gene assay for ETV6 mediated transcriptional 
repression. Full length ETV6 and amino acids 282-345 of ETV6 (the TIP60β interaction 
domain of ETV6) fused to the GAL4DBD were tested for their ability to repress 
transcription of a luciferase reporter gene in HEK293 cells. The mean and standard 
deviation of the normalized firefly luciferase values from three experiments are shown. 
Transfected plasmids are shown below the bar graph. The raw data of this experiment are 
given in the Appendix. See text for explanation and interpretation. 
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Fig. 4.14  Stromelysin-1 promoter based reporter gene assay  for ETV6 and ETV6 
serine to alanine mutant mediated transcriptional repression. CFP-ETV6 and three serine 
to alanine mutants(CFP-ETV6(S106A), CFP-ETV6(S257A) and CFP-ETV6 (S332A)) 
were tested for their ability to repress transcription of a luciferase reporter gene in 
HEK293 cells. The mean and standard deviation of the normalized firefly luciferase values 
from three experiments are shown. Transfected plasmids are shown below the bar graph. 
The raw data of this experiment are given in the Appendix. See text for explanation and 
interpretation. 
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Plasmid 1 2 3 4 5 6 
pTK Luc + + + + + + 
pM1 ETV6   + +   
pM1 ETV6 
(282-345)     + + 
TSA (75 nM)  +  +  + 
 
Fig. 4.15  GAL4(5)-tk-Luc based reporter gene assay demonstrating the effect of the 
HDAC inhibitor TSA on ETV6 mediated transcriptional repression. Full length ETV6 and 
amino acids 282-345 of ETV6 (the TIP60β interaction domain of ETV6) fused to the 
GAL4DBD were tested for their ability to repress transcription of a luciferase reporter gene 
in HEK293 cells in the presence and absence of 75 nM TSA. The mean and standard 
deviation of the normalized firefly luciferase values from three experiments are shown. 
Transfected plasmids are shown below the bar graph. The raw data of this experiment are 
given in the Appendix. See text for explanation and interpretation. 
 
 
4.3.3.2  Function of TIP60β in the reporter assays 
 
Depending on its interaction partners, TIP60 functions as a transcriptional 
co-activator or as a transcriptional corepressor. Interestingly, we found that 
the expression of a TIP60β-YFP fusion protein shows opposite effects in the 
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two reporter systems used in this study. While there was a slight (1.6 fold) 
activation of transcription when the GAL4(5)-tk-Luc reporter plasmid was 
used (Fig 4.16) there was a slight repression (down to 70% of the control 
value) of transcriptional activity when the stromelysin-1 promoter based 
reporters were used (pTR344 and pTR89) (Fig 4.17). Although, these effects 
were not very large they were consistently found. Since TIP60 is not known 
to have a DNA binding domain and this effect is also seen when pTR89 
which does not have any ets binding sites is used, these effects are most 
likely indirect general effects on transcription. 
 
 
 
 
 
                                                                           
  
Plasmid 1 2 
pTK- Luc + + 
pEYFP-N1-TIP60β  + 
 
Fig. 4.16  Expression of a TIP60β-YFP fusion protein leads to enhanced activity of 
firefly luciferase with the GAL4(5)-tk-Luc based reporter in HEK293 cells. The mean and 
standard deviation of the normalized firefly luciferase values from three experiments are 
shown. Transfected plasmids are shown below the bar graph. The raw data of this 
experiment are given in the Appendix. See text for explanation and interpretation.  
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Fig. 4.17  Expression of a TIP60β-YFP fusion protein leads to a decrease in firefly 
luciferase activity with the stromelysin-1 promoter based reporter (pTR344 and pTR89) in 
HEK293 cells. The mean and standard deviation of the normalized firefly luciferase values 
from three experiments are shown. Transfected plasmids are shown below the bar graph. 
The raw data of this experiment are given in the Appendix. See text for explanation and 
interpretation.  
 
4.3.3.3  The HAT deficient mutant of TIP60β lacks transcriptional activity 
 
As shown in figure 4.17, TIP60β-YFP shows modest transcriptional 
repression activity when pTR334 is used as a reporter gene. When the 
histone acetyltransferase deficient DRS mutant of TIP60β-YFP was used, no 
difference in the transcriptional activity of the luciferase reporter gene was 
Plasmid 1 2 3 4 
pTR 89 + +   
pTR 334   + + 
pEYFP-N1-TIP60β  +  + 
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observed (compare bar 1 and 3 in Fig. 4.18). This indicates that the 
acetyltransferase function of TIP60β is required for its transcriptional effects. 
 
  
 
Plasmid 1 2 3 4 5 6 
pTR 334 + + + + + + 
pEYFP 
N1-TIP60β  +   +  
pEYFP 
N1-TIP60β (DRS)   +   + 
pECFP C1-ETV6    + + + 
 
Fig. 4.18  Expression of the HAT deficient TIP60β(DRS)-YFP fusion protein does not 
change the firefly luciferase activity with the stromelysin-1 promoter based reporter 
(pTR344) in HEK293 cells. The mean and standard deviation of the normalized firefly 
luciferase values from three experiments are shown. Transfected plasmids are shown 
below the bar graph. The raw data of this experiment are given in the Appendix. See text 
for explanation and interpretation.  
 
4.3.3.4 Effect of PIN1 in the stromelysin-1 promoter based reporter assay 
 
Although PIN1 has no DNA binding site, the expression of PIN1-YFP resulted 
in a 1.5 fold increased expression of the firefly luciferase reporter gene when 
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the pTR334 reporter plasmid was used in HEK293 cells (Fig. 4.19). The 
pTR344 reporter plasmid contains an ets (EBS) and two potential ets binding 
sites (TBS). These sites are absent in pTR89. It is thus conceivable that the 
positive effect of PIN-YFP on the transcription of the reporter gene is 
mediated through regulation of a cellular ets factor by PIN1.  
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Plasmid 1 2 3 4 
pTR 89 + +   
pTR 334   + + 
pEYFP-N1-PIN1  +  + 
 
Fig. 4.19  Expression of a PIN1-YFP fusion protein leads to an increase in firefly 
luciferase activity with the stromelysin-1 promoter based reporter pTR334 but not with the 
pTR89 reporter, which lacks ets and ETV6 DNA binding sites, in HEK293 cells. The mean 
and standard deviation of the normalized firefly luciferase values from three experiments 
are shown. Transfected plasmids are shown below the bar graph. The raw data of this 
experiment are given in the Appendix. See text for explanation and interpretation.  
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4.3.4 The transcriptional repression function of ETV6 is modified by TIP60β 
and PIN1 
 
4.3.4.1 TIP60β is a co-repressor of ETV6 in the GAL4(5)-pTK-Luc reporter 
system  
 
When TIP60β-YFP is coexpressed with GAL4DBD-ETV6, the transcription of 
the firefly luciferase reporter gene from the GAL4(5)-tk-Luc plasmid is 
strongly repressed (about 34 fold). This repression is about twice as strong 
as seen with GAL4DBD-ETV6 alone (Fig 4.20, No. 3 and 4). The same 
enhanced repression of the reporter gene upon coexpression of TIP60β-YFP 
is seen when only the TIP60β interaction domain of ETV6 (aa282-345) fused 
to the GAFL4DBD is expressed. GAL4DBD-ETV6(282-345) shows a very 
modest repressional activity of about 1.7 fold. However, when TIP60β-YFP is 
coexpressed, this repression is enhanced considerably (Fig 4.20, No. 5 and 
6). 
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Plasmid 1 2 3 4 5 6 
GAL4(5)-TK-Luc + + + + + + 
pM1-ETV6   + +   
pM1-ETV6 
(282-345) 
    + + 
pEYFP-N1-TIP60β  +  +  + 
 
Fig. 4. 20  Coexpression of a GAL4DBD-ETV6 or a GAL4DBD-ETV6(282-345) fusion 
protein with TIP60β-YFP leads to enhanced repression of the firefly luciferase reporter 
gene from the GAL4(5)-tk-Luc reporter plasmid in HEK293 cells. The mean and standard 
deviation of the normalized firefly luciferase values from three experiments are shown. 
Transfected plasmids are shown below the bar graph. The raw data of this experiment are 
given in the Appendix. See text for explanation and interpretation.  
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4.3.4.2 TIP60β is a co-repressor of ETV6 in the stromelysin-1 based 
reporter system  
 
The results of the experiments in Fig 4.20 clearly show that TIP60β acts as a 
corepressor of ETV6 when ETV6 is fused to a heterologous DNA binding 
domain. To analyze whether this corepressor activity would also be found in 
situations where ETV6 uses its ets domain for DNA binding, coexpression 
studies of ETV6 and TIP60β were performed in the stromelysin-1 based 
reporter system. The expression of TIP60β-YFP leads to a modest 1.5 fold 
repression of reporter gene activity and the expression of CFP-ETV6 to a 2 
fold repression when the pTR344 reporter was used (Fig. 4.21, No. 5, 6 and 
7). However, when both CFP-ETV6 and TIP60β-YFP were coexpressed a 
syngergistic increase of repression to 4 fold was observed (Fig. 4.21, No. 8). 
When this experiment was repeated with a reporter that lacked both the EBS 
and TBS (pTR89), similar results were observed, however at a much lower 
overall level of reporter gene expression (Fig. 4.21, No 1 to 4) 
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Fig. 4. 21  Coexpression of a CFP-ETV6 fusion protein with TIP60β-YFP leads to 
enhanced repression of the firefly luciferase reporter gene from the stromelysin-1 
promoter luciferase reporter plasmid in HEK293 cells. The mean and standard deviation 
of the normalized firefly luciferase values from three experiments are shown.  
Transfected plasmids are shown below the bar graph. The raw data of this experiment are 
given in the Appendix. See text for explanation and interpretation. 
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4.3.4.3.  The phosphorylation of Ser257 on ETV6 is important for the 
interaction with TIP60β 
 
The results in Fig. 4.20 and Fig. 4.21 clearly show that TIP60β is a 
transcriptional corepressor of ETV6. The experimental results shown in Fig. 
4.14 demonstrate that two of the CFP-ETV6 serine to alanine mutants 
(S106A and S257A) have slightly stronger repressional activity than 
CFP-ETV6. The S332A mutant showed a similar repressional activity like the 
wild type ETV6. Ser257 of ETV6 is known as a p38 dependent 
phosphorylation site (Arai et.al., 2002). Therefore the ability of TIP60β to 
function as a corepressor for these serine to alanine mutant CFP-ETV6 
proteins was examined (Fig. 4.22). When the CFP-ETV6 serine to alanine 
mutants and TIP60β-YFP were coexpressed, corepressor activity of TIP60β 
could only be seen for the S106A and the S332A mutants (compare no. 5 and 
6, and no. 9 and 10) but not for the S257A mutant (compare no. 7 and 8). 
This implies that the phosphorylation of Ser257 on ETV6 is important for this 
functional interaction with TIP60β.  
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Fig. 4.22  Stromelysin-1 promoter based reporter gene assay for corepressor activity of 
TIP60β and ETV6 serine to alanine mutants in HEK293T cells. The mean and standard 
deviation of the normalized firefly luciferase values from three experiments are shown. 
Transfected plasmids are shown below the bar graph. The raw data of this experiment are 
given in the Appendix. See text for explanation and interpretation. 
 
4.3.4.4  PIN1 reduces the transcriptional repression of ETV6  
 
When PIN1-YFP was coexpressed with the GAL4DBD-ETV6 fusion protein 
the ability of GAL4DBD-ETV6 to repress transcription of the firefly luciferase 
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reporter gene from the GAL4(5)-tk-Luc reporter was reduced from 7 fold 
repression in the absence of PIN1-YFP to only about two fold in the the 
presence of PIN1-YFP (Fig 4.23, compare No. 1 and 2 and No. 3 and 4). The 
expression of PIN1-YFP alone led to a slight reduction in reporter gene 
expression (Fig 4.23; compare No. 1 and 3). 
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Plasmid 1 2 3 4 
pGAL4(5)- TK Luc + + + + 
pM1-ETV6  +  + 
pEYFP-N1-PIN1   + + 
 
Fig. 4. 23  Coexpression of a GAL4DBD-ETV6 fusion protein with PIN1-YFP leads to 
reduced repression of the firefly luciferase reporter gene from the GAL4(5)-tk-Luc reporter 
plasmid in HEK293 cells. The mean and standard deviation of the normalized firefly 
luciferase values from three experiments are shown. Transfected plasmids are shown 
below the bar graph. The raw data of this experiment are given in the Appendix. See text 
for explanation and interpretation.  
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4.3.4.5.  Effect of PIN1 on the function of the pointed domain and the function 
of C terminal half of the central domain of ETV6  
 
PIN1 reduces the transcriptional repression of ETV6 in the GAL4(5)-tk-Luc 
reporter system. Using two deletion mutants of ETV6 fused to the GAL4DBD, 
we tried to map the domain of ETV6 that is responsible for this effect. The 
first deletion mutant of ETV6 that was tested contained the C terminal half of 
the central domain (aa282-345); this is also the TIP60β interaction domain of 
ETV6. While the repression of GAL4DBD-ETV6 was slightly reduced by the 
coexpression of YFP-PIN1 (Fig. 4.24 compare No. 1 and 3, and No. 3 and 4), 
there was no appreciable effect of coexpression of PIN1-YFP for this mutant. 
With or without PIN1-YFP, expression of GAL4DBD-ETV6(282-345) resulted 
in a two fold reduction of the firefly luciferase expression (Fig. 4.24 compare 
No. 1 and 5, and No. 2 and 6). However, the situtation was slightly different 
when the GAL4DBD-ETV6 (1-126), which included the pointed domain of 
ETV6, was tested with or without PIN1-YFP: there was a very slight increase 
of repressional acitivity of the GAL4DBD-ETV6(pointed) fusion in the 
presence of PIN1-YFP (Fig. 4.24, compare No. 1 and 7, and No. 2 and 8).  
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Plasmid 1 2 3 4 5 6 7 8 
pGAL4(5)- 
TK Luc 
+ + + + + + + + 
pM1-ETV6   + +     
pM1-ETV6 
(282-345) 
    + +   
pM1-ETV6 
(1-126) 
      + + 
pEYFP-N1-
PIN1 
 +  +  +  + 
 
Fig. 4.24  Effect of PIN1-YFP expression on the transcriptional acitivity of GAL4DBD- 
ETV6 deletion mutants (aa 282-345 and aa 1-126) on the expression of the firefly 
luciferase reporter gene from the GAL4(5)-tk-Luc reporter plasmid in HEK293 cells. The 
mean and standard deviation of the normalized firefly luciferase values from three 
experiments are shown. Transfected plasmids are shown below the bar graph. The raw 
data of this experiment are given in the Appendix. See text for explanation and 
interpretation. 
 
 
 
0
0. 1
0. 2
0. 3
0. 4
0. 5
0. 6
0. 7
0. 8
0. 9
1 2 3 4 5 6 7 8
- 6.6 x- 3.9 x
- 2.1 x - 2.4 x
- 6.4 x - 4.7 x
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
131 
4.3.4.6  Coexpression of PIN1 transforms ETV6 from a transcriptional 
repressor to a transcriptional activator 
 
To examine the effect of PIN1-YFP expression on the function of ETV6 in a 
more physiological promoter setting, the stromelysin-1 promoter based 
reporter system was used. In this system the transcriptional activity of ETV6 
is dependent on the DNA binding domain of ETV6. As was shown above (Fig. 
4.19), expression of PIN1-YFP results in a slight increase in the expression 
of the firefly luciferase reporter gene from the pTR344 plasmid (Fig. 4.25, 
compare No. 5 and 6, 1.5 fold). Also as shown before, expression of 
CFP-ETV6 leads to a repression of the transcription of the reporter gene (Fig 
4.25, compare No. 5 and 7). However, when PIN1-YFP and CFP-ETV6 are 
coexpressed, a moderate transcriptional activation (2.2 fold) is observed 
which is much stronger than when PIN1-YFP is expressed alone (Fig. 4.25, 
No. 8). This means that PIN1 does not only abolish ETV6 mediated 
transcriptional repression, but that PIN1 converts ETV6 from a transcriptional 
repressor to a transcriptional activator.  
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Plasmid 1 2 3 4 5 6 7 8 
pTR 89 + + + +     
pTR 334     + + + + 
pECFP C1 ETV6   + +   + + 
pEYFP N1PIN1  +  +  +  + 
 
Fig. 4. 25  Coexpression of a CFP-ETV6 fusion protein with PIN1-YFP leads to greatly 
enhanced expression of the firefly luciferase reporter gene from the stromelysin-1 
promoter luciferase reporter plasmid in HEK293 cells. ETV6 is turned from a 
transcriptional repressor to a transcriptional activator. The mean and standard deviation of 
the normalized firefly luciferase values from three experiments are shown. Transfected 
plasmids are shown below the bar graph. The raw data of this experiment are given in the 
Appendix. See text for explanation and interpretation. 
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implied that the SAM/pointed domain and the central domain of ETV6 contain 
the PIN1 interacting sites (see Fig. 4.5). Serine to alanine mutants at the 
Ser-Pro bonds at positions 106, 257 and 332 of ETV6, which represent 
potential PIN1 interaction motifs, were tested in the stromelysin-1 promoter 
based reporter gene system for their functional interaction with PIN1 (Fig. 
4.26). PIN1 is able to completely block the repressional acitivity of ETV6 and 
in some cases even turn ETV6 into an activator of transcription. While the 
repressional acitivity of the ETV6 serine to alanine mutants at positions 257 
and 332 were blocked by PIN1 (compare no. 7 and 8, and no 9 and 10 in Fig. 
4.26), this was not the case for the ETV6 serine to alanine mutant at position 
106 (compare no. 5 and 6 in Fig. 4.26). The ETV6 (S106A) mutant was 
completely resistant to the influence of PIN1 and exhibited full repressional 
activity. These findings imply that a conformational change through prolyl-cis 
trans isomerization at the Ser106-Pro107 bond mediated through PIN1 after 
phosphorylation of ETV6 at serine 106 cause ETV6 to lose its repressional 
activity. 
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Fig. 4.26  Stromelysin-1 promoter based reporter gene assay to examine the effects of 
PIN1 on ETV6 serine to alanine mutants in HEK293T cells. If residue 106 of ETV6 is 
mutated from a serine into an alanine PIN1 is no longer able to block ETV6 mediated 
repression. The mean and standard deviation of the normalized firefly luciferase values 
from three experiments are shown. Transfected plasmids are shown below the bar graph. 
The raw data of this experiment are given in the Appendix. See text for explanation and 
interpretation. 
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4.3.4.8  The corepression function of TIP60β for ETV6 is independent of 
HDACs 
 
Transcriptional repression by a transcription factor is often mediated through 
the recruitment of corepressors which themselves recruit histone 
deacetylases. In Fig. 4.15 it could be shown that part of the trancriptional 
repression function of ETV6 can be relieved by blocking HDACs with 
trichostatin A (TSA). Using the GAL4(5)-tk-Luc reporter system we examined 
whether the corespressor effect of TIP60β is dependent on HDAC acitivity. 
Even in the presence of TSA, the expression of TIP60β-YFP still causes 
corepression (Fig. 4.27, compare No. 3, No. 5 and 7, and No. 4, No. 6 and 8). 
This independence of TIP60β corepressor acitivity was even more obvious 
when only the TIP60β interaction domain of ETV6 was expressed as a fusion 
with GAL4DBD (GAL4DBD-ETV6(282-345). Even when HDACs were 
inhibited by TSA, TIP60β-YFP represses transcription of the reporter gene 
together with GAL4DBD-ETV6(282-345) (Fig. 4.27, compare No. 10 and 12). 
Neither TIP60β-YFP (Fig. 4.27, No.4) nor GAL4DBD-ETV6 (282- 345) alone 
(Fig. 4.27, No. 10) were able to repress transcription in the presence of TSA. 
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Plasmid 1 2 3 4 5 6 7 8 9 10 11 12 
pTK Luc + + + + + + + + + + + + 
pM1 ETV6     + + + +     
pM1 ETV6 
(282-345) 
        + + + + 
pEYFP 
N1TIP60β 
  + +   + +   + + 
TSA  +  +  +  +  +  + 
 
Fig. 4. 27  GAL4(5)-tk-Luc based reporter gene assay demonstrating the independence 
of the TIP60β corepressor effect from HDACs. Full length ETV6 and amino acids 282-345 
of ETV6 (the TIP60β interaction domain of ETV6) fused to the GAL4DBD and 
TIP60β-YFP were tested for their ability to repress transcription of a luciferase reporter 
gene in HEK293 cells in the presence and absence of 75 nM TSA. The mean and 
standard deviation of the normalized firefly luciferase values from three experiments are 
shown. Transfected plasmids are shown below the bar graph. The raw data of this 
experiment are given in the Appendix. See text for explanation and interpretation. 
 
 
4.3.5  The role of ETV6, TIP60β and PIN1 in cell cycle regulation 
 
PIN1 has been shown to play an important role in cell cycle regulation. 
Overexpressing of PIN1 causes cell cycle arrest in the G2 phase of the cell 
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cycle (Lu et al., 1996). This part of my work will focus on the effects of 
overexpression of ETV6, TIP60β and PIN1 on the cell cycle of HEK 293T 
cells. 
 
4.3.5.1  The effect of the expression of the fluorescence proteins GFP and 
YFP on HEK 293T cell cycle regulation 
 
Since the ETV6, TIP60β and PIN1 proteins used in this experiment are fused 
to the GFP or YFP fluorescent proteins, the effect of GFP and YFP 
expression on the cell cycle of 293T cells was tested first. For the analysis of 
the cell cycle, the DNA content of the cells was measured by Hoechst 334 
staining. The primary FACS data were analyzed in the following way: First life 
cells were gated using forward and side scatter. Then the GFP, YFP or 
GFP/YFP postive cells were gated and their DNA contents was measured 
with the Hoechst stain (Fig. 4.28 A.). 
 
When the transfected cells were observed under the micoroscope around 
90% were GFP or YFP positive. However, the FACS analysis was only able 
to identify around 20% of cells as positive. This can probably be explained by 
different expression levels of GFP and YFP in the cells. This means that 
about 70% of GFP or YFP negative cells as identified by FACS were also 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
138 
transfected and expressed the fluorescent proteins to a lesser extent. When 
we analyzed the Hoechst stain in the FACS GFP positive and FACS GFP 
negative groups no difference in the relative distribution of cells in the 
different cell cycle phases was observed (Fig. 4.28D). This meant that the 
GFP or YFP negative cells that were identified by FACS could not be used as 
a control in our cell cycle experiments. We therefore used mock transfected 
cells as controls. The initial experiments showed that the expression of the 
fluorescent proteins GFP, YFP, and GFP/YFP increased the proportion of 
cells in S/G2/M phase from 13% to between 30 to 34% (Fig. 4.28 B and C). 
A.    
 
 
 
 
B. 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
293T GFP YFP GFP/YFP
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
139 
 
                     
D. 
0%
10%
20%
30%
40%
50%
60%
70%
GFP negative GFP positive
 
 
 
 
 
 
 
 
 1 2 3 4 
Cycle phase 293T GFP YFP GFP+YFP 
G1(blue) 86.88% 65.59% 70.06% 68.51% 
S+G2/M 
(yellow) 13.12% 34.41% 29.94% 31.49% 
 1 2 
Cycle phase GFP negative GFP positive 
G1(blue) 59% 59.03% 
S+G2/M 
(yellow) 41% 40.97% 
C. 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
140 
 
Fig. 4.28  Effect of overexpression of GFP and YFP on the cell cycle of 293T cells. 
293T cells were transfected with pEGFP-C1, pEYFP-N1 or both plasmids together. The 
293T control and transfected positive cells were harvested after 48 hours and stained with 
propidium iodide (PI) and Hoechest 334. A) The process for analyzing the primary data B) 
Histograms for the Hoechest 334 stain of GFP, YFP or GFP and YFP positive cells. C) Bar 
graph showing the percentage of cells ins G1 phase (blue) and S/G2/M phases (yellow). D) 
The contribution of FACS GFP positive and FACS GFP negative groups to cell cycle 
phases 
 
 
4.3.5.2  Effect of ETV6 on the cell cycle 
 
The expression of the GFP-ETV6 fusion protein in 293T cells caused a slight 
increase (from 65 to 71%) in the proportion of cells in G1 phase (Fig. 4.29A 
and B, lane 3), 6% more than GFP expressed cells (Fig. 4.29B, lane 2). 
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Fig. 4.29  Effect of overexpression of GFP-ETV6 on the cell cycle of 293T cells. 293T 
cells were transfected with pEGFP-ETV6 or pEGFP. The cells were harvested after 48 
hours and stained with propidium iodide (PI) and Hoechst 334. A) Histograms for the 
Hoechst stain of GFP-ETV6, or GFP positive cells. B) Bar graph showing the percentage 
of cells ins G1 phase (blue) and S/G2/M phases (yellow). 
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4.3.5.3  Effect of TIP60β on the cell cycle  
 
The expression of TIP60β-YFP in 293T cells caused a marked increase of 
cells in G1 phase (Fig. 4.30 A, B lane 3) compared to YFP expressing 293T 
cells (Fig. 4.30A, B lane 2). The analysis of TIP60β-YFP expressing cells 
showed that 86.65% of the cells were in G1 phase, with just 13.25% in 
S/G2/M phase (Fig. 4.30 B). 
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Fig. 4.30  Effect of overexpression of TIP60β-YFP on the cell cycle of 293T cells. 293T 
cells were transfected with pEYFP-N1- TIP60β or pEYFP. The cells were harvested after 
48 hours and stained with propidium iodide (PI) and Hoechst 334. A) Histograms for the 
Hoechst stain of TIP60β-YFP, or YFP positive cells. B) Bar graph showing the percentage 
of cells ins G1 phase (blue) and S/G2/M phases (yellow). 
 
4.3.5.4  Effect of PIN1 on the cell cycle  
 
The overexpression of PIN1 is known to arrest cells in G2 phase . Our data of 
PIN1-YFP transfected 293T cells showed a similar result. 63.29% of 
PIN1-YFP positive cells were in G1 phase and 36.71% were in S/G2/M (Fig. 
4.31 A and B). 
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Fig. 4.31  Effect of overexpression of PIN1-YFP on the cell cycle of 293T cells. 293T 
cells were transfected with pEYFP-N1-PIN1 or pEYFP. The cells were harvested after 48 
hours and stained with propidium iodide (PI) and Hoechst 334. A) Histograms for the 
Hoechst stain of PIN1-YFP or YFP positive cells. B) Bar graph showing the percentage of 
cells ins G1 phase (blue) and S/G2/M phases (yellow). 
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4.3.5.5  Effect of coexpression of GFP-ETV6 and TIP60β-YFP on the cell 
cycle  
 
Coexpression of GFP-ETV6 and TIP60β-YFP in 293T cells had almost the 
same effect as expressiong GFP-ETV6 only (Fig. 4.32 A). 72.31% of 
GFP-ETV6 and TIP60β-YFP positive cells were in G1 phase and 27.69% 
cells were in S/G2/M phase (Fig. 4.32 B). 
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Fig. 4.32  Effect of coexpression of GFP-ETV6 and TIP60β-YFP on the cell cycle of 
293T cells. 293T cells were transfected with pEGFP-C1-ETV6, pEYFP-N1-TIP60β and 
with both plasmids together. The cells were harvested after 48 hours and stained with 
propidium iodide (PI) and Hoechst 334. A) Histograms for the Hoechst stain of GFP-ETV6, 
TIP60β-YFP, or for the double positive cells. B) Bar graph showing the percentage of cells 
ins G1 phase (blue) and S/G2/M phases (yellow). 
 
4.3.5.5  Effect of coexpression of GFP-ETV6 and PIN1-YFP on the cell cycle  
 
Coexpression of GFP-ETV6 and PIN1-YFP resulted in a slight increase of cells in the 
S/G2/M phase compared to cells expressing GFP-ETV6 alone (32% versus 29%). The 
percentage of cells in S/G2/M phase was not as high as in the cells which expressed 
PIN1-YFP only (Fig. 4.33). 
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Fig. 4.33  Effect of coexpression of GFP-ETV6 and PIN1-YFP on the cell cycle of 293T 
cells. 293T cells were transfected with pEGFP-C1-ETV6, pEYFP-N1-PIN1 and with both 
plasmids together. The cells were harvested after 48 hours and stained with propidium 
iodide (PI) and Hoechst 334. A) Histograms for the Hoechst stain of GFP-ETV6, PIN1-YFP, 
or for the double positive cells. B) Bar graph showing the percentage of cells in G1 phase 
(blue) and S/G2/M phases (yellow). 
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5.  Discussion 
 
5.1  ETV6 
 
The ETV6 protein can be divided into three functional domains: the pointed 
or SAM (sterile alpha motif) domain, the central domain and the ets DNA 
binding domain.  
 
The SAM/pointed domain of ETV6 is a dimerization and oligomerization 
domain for ETV6 and several ETV6 fusion proteins (e.g. ETV6-NTRK3). The 
crystal structure of the pointed domain oligomer shows a helical head-to-tail 
structure. ETV6-pointed domain oligomers were also observed under the 
electron microscope. The formation of these polymeric structures by 
SAM/pointed domains in two different transcriptional repressors (ETV6 and 
polyhomeotic) suggests a conserved mode of repression involving a higher 
order chromatin structure (Kim et al., 2001; Kim et al., 2002). The pointed 
domain mediated dimerization is essential for the constitutive activation of 
the ETV6-tyrosine kinase fusion protein (Golub et al., 1996). More recent 
studies on ETV6-NTRK3 show that the pointed domain is important for the 
oligomerization of this fusion protein in vivo. When the pointed domain of 
ETV6-NTRK3 was replaced by an inducible dimerization domain of the 
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FK506 binding protein (FKBP), this new fusion protein failed to transform 
NIH3T3 cells when dimerization was not induced. So the transforming 
potential of ETV6-NTRK3 which is found in different types of solid tumors 
depends on the pointed domain mediated oligomerization. An ETV6-NTRK3 
fusion protein with a mutated pointed domain did not dimerize in vivo and 
showed no transforming potential (Tognon et al., 2004). These results show 
that the pointed domain plays an important role for the function of ETV6 and 
of ETV6 fusion proteins. 
 
The pointed domain is not only important for ETV6 oligomerization but is also 
an important protein-protein interaction interface. ETV6 interactions with the 
ets protein FLI1 (Kwiatkowski et al., 1998) and the SUMO conjugating 
enzyme UBC9 are mediated through the pointed domain (Chakrabarti and 
Nucifora, 1999; Chakrabarti et al., 1999). The polycomb group protein 
H-L(3)MBT (human lethal(3)malignant brain tumor) interacts with ETV6 
through the SAM domain as well. H-L(3)MIBT is a transcriptional regulator 
with a C-terminal SPM domain which is structurally related to the 
SAM/pointed domain. The SPM domain of H-L(3)MIBT interacts with ETV6 in 
vitro and in vivo. This interaction enhanced the transcriptional repression 
caused by ETV6 on a stromelysin-1 promoter luciferase reporter gene 
(Boccuni et al., 2003). The pointed domain of ETV6 is sumoylated at lysine 
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99 by UBC9. SUMO-1 (small ubiquitin-like modifier) conjugation enhances 
the nuclear export of ETV6 which leads to reduced ETV6 transcriptional 
repression activity (Wood et al., 2003).  
 
In our study, the pointed domain of ETV6 did not interact with TIP60β in the 
yeast system (Fig. 4.3). However, the N terminal 126 amino acids of ETV6 
which include the pointed domain, showed interaction with PIN1 in the yeast 
two-hybrid system (Fig. 4.5). In the mammalian two hybrid system, the 
N-terminal domain which included the pointed domain showed a much 
stronger interaction with PIN1 than full length ETV6. (Putnik, Ph.D. thesis, 
2001). The interaction between PIN1 and the ETV6 SAM/pointed domain is 
probably different from the interactions of ETV6 with FLI1 or H-L(3)MBT 
which use their own SAM or SAM like domains for binding. There is no 
SAM-like domain in PIN1. PIN1 probably recognizes the phosphorylated 
serine at postition 106 in the ETV6 pointed domain, which precedes a proline. 
This is the typical recognition motif for PIN1 binding (Joseph et al., 2003). 
Interestingly, the ETV6(S106A) mutant had a stronger repression activity 
than wild type ETV6 and this mutant was not responsive to PIN1 
coexpression (Fig. 4.26). It appears thus very likely that the serine at position 
106 in the pointed domain is very important for modulating the function of 
ETV6. 
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The other well-known functional domain of ETV6 is the 85 amino acid long 
ets DNA binding domain. This domain specifically binds to DNA segments 
with a GGAA/T core recognition sequence. The only leukemia-associated 
fusion protein where the ets domain is present in the critical fusion protein is 
the MN1-ETV6 fusion. The MN1-ETV6 fusion protein, which is found in acute 
myeloid leukaemia (AML), consists of an N-terminus derived from MN1 
(Meningioma 1) and a C-terminus comprising the ets domain of ETV6. This 
fusion protein can transform NIH3T3 cells and its transformation potential is 
dependent on both the N-terminal MN1 portion and the ETV6 ets domain. 
Interestingly, this fusion protein showed transcriptional activator function, 
which also depended on both the domains from MN1 and the ets domain of 
ETV6 (Buijs et al., 2000). We did not detect any interaction between the 
isolated ets domain of ETV6 and TIP60β (Fig. 4.3) or PIN1 (Fig. 4.5). 
 
The pointed domain and the central domain of ETV6 are present in most 
fusion proteins (especially in the very common ETV6/AML1 fusion). This 
implies that the central domain of ETV6 might play a significant role in the 
function of ETV6 and the fusion proteins. It could be demonstrated that this 
region interacts with a repression protein complex including SMRT (Silencing 
mediator of retinoic acid and thyroid hormone receptor) and mSin3A, which 
act as transcriptional co-repressors for ETV6/TEL. (Chakrabarti and Nucifora, 
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1999; Fenrick et al., 1999). Another protein that interacts with the central 
domain of ETV6 is N-CoR (Nuclear receptor co-repressor) (Guidez et al., 
2000). In our studies, the central domain of ETV6 is an important domain for 
the interaction with both TIP60β and PIN1. Mapping of the TIP60β interacting 
domain of ETV6 in yeast shows that the whole central domain of ETV6 
interacts with full length TIP60β. The TIP60β interacting domain of ETV6 can 
be narrowed down to the C-terminal part of the central domain (aa 282-345) 
and to a 23 amino acid long stretch of this region (aa 314-336) (Fig. 4.3). 
Nordentoft and Jorgensen reported in 2003 that the C-terminal region of the 
central domain and the ets domain of ETV6 contribute to the interaction with 
TIP60 as assayed in yeast. Mapping of the PIN1 interaction domain of ETV6 
in the yeast two-hybrid system also showed that the C-terminal portion of the 
central domain (aa 282-345) could interact with PIN1 (Fig. 4.5). The serine to 
alanine point mutant at position 257 of ETV6 showed increased 
transcriptional repression activity in the stromelysin-1 promoter-based 
reporter assay compared to the wild type pTR334 luciferase gene reporter 
system (Fig. 4.14). This result suggests that Ser257 in the central domain of 
ETV6 might be an important site for the modulation of ETV6 repression 
function by PIN1. 
 
Up to now, about 8 ETV6 interacting proteins have been shown to bind at the 
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pointed domain or the central domain of ETV6. These interactions influence 
the cellular localization or the transcriptional function or both of ETV6 (Fig. 
5.1). 
 
 
Fig. 5.1  ETV6 interacting proteins (upper part of figure) and ETV6 fusion partners (lower 
part of figure) 
 
 
5.2  TIP60β and the ETV6-TIP60β interaction 
 
TIP60 is a MYST domain histone acetyltransferase which catalyzes the 
acetylation of histones H4 and H2. Several recent studies have shown that 
TIP60 has not only histones as substrate but that it also interacts with 
numerous proteins in the cytoplasm and the nucleus. A TIP60 protein 
 MN1       STL 
BTL        ARNT
HLXB9     PAX5 
MDS2      TTL 
ACS2
 RUNX 1 
 
EVI 1 
ETV6 (TEL) 
 ARG NTRK3 
PDGFR
B 
JAK 2 
ABL 
SYK
1      38      123                            338         422  452 
pointed ETS 
FL 1  L(3)MBT 
UBC9  SUMO-1 
PIN1 
N-CoR  SMRT
mSin3A  TIP60
GGAA/T 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
154 
complex was described which contains more than 13 proteins and has 
histone acetylase, ATPase, DNA helicase and structural DNA binding 
activities. This complex was shown to be involved in DNA repair and 
apoptosis (Ikura et al., 2000). The MYST domain of TIP60 consists of a Zinc 
finger and a histone co-enzyme A binding site. The MYST domain plays an 
important role in the function of TIP60 as a protein-interaction domain (zinc 
finger) and as the acetyltransferase domain. TIP60 acts as a transcriptional 
co-regulator. It is a transcriptional co-repressor for STAT3, CREB, ZEB and 
ETV6/TEL or a transcriptional co-activator for HIV1 TAT, the class I nuclear 
hormone receptors, for APP (beta -Amyloid Precursor Protein) and the AR 
(androgen receptor).  
 
TIP60 has been shown to affect the stability and the subcellular localization 
of its interacting partner PIRH2, which also interacts with p53 (Logan et al., 
2004). TIP60 and p53 are both modified by the ubiquitin ligase MDM2 
(Katayama et al., 2004; Legube et al., 2002). 
 
TIP60 was identified as an ETV6 interacting protein (Bohlander et al., 2001; 
Nordentoft and Jorgensen, 2003).  
 
It could be shown that the phosphorylation of TIP60 is enhanced by drug 
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induced arrest of cells in G2/M phase. Phosphorylation of TIP60 is important 
for its acetytransferase activity (Lemercier et al., 2003). Our analysis showed 
that expression of TIP60β can increase the proportion of 293T cells in G1 
phase (Fig. 4.30). Coexpression of TIP60β and ETV6 reduced the number of 
cells in G1 phase again (Fig. 4. 33).  
 
Our co-localization data showed that the interaction between TIP60β and 
ETV6 influences the subcellular localization of ETV6. When more TIP60β 
was expressed, more ETV6 was localized in the nucleus together with 
TIP60β (Fig. 4.11). The subnuclear localization of ETV6 is regulated by 
sumoylation of ETV6. Sumoylation of ETV6 enhances nuclear export of the 
protein (Wood et al., 2003). Our data suggest that the interaction between 
TIP60β and ETV6 might lead to an enhanced transcriptional repression by 
keeping ETV6 in the nucleus for a longer time. 
 
We could demonstrate that TIP60β is a transcriptional co-repressor of ETV6 
using two different reporter gene assays. First a reporter plasmid was used in 
which the firefly luciferase reporter gene was under the control of GAL4 
binding sites and the Herpes Simplex virus thymidine kinase promoter. This 
plasmid expresses luciferase at a relatively high level. Upon expression of 
ETV6 fused to the GAL4 DNA binding domain (GAL4DBD) a strong 
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repression of luciferase expression was observed. This repression was 
slightly enhanced by cotransfecting TIP60β suggesting a co-repressor role 
for TIP60β (Fig 4.20).  When only the TIP60β interaction domain of ETV6 
(aa282-345) fused to the GAL4DBD was expressed the repression observed 
was very mild. However, co-expression of TIP60β with the 
GAL4DBD-ETV6(282-345) showed a clear co-repression activity of TIP60β. 
This co-repression function of TIP60 for ETV6 was described in a similar 
system by Nordentoft and Jorgensen (Nordentoft and Jorgensen, 2003). 
Expression of TIP60β alone (a TIP60β-YFP fusion protein) led to a slight 
increase in reporter gene repression. Since TIP60β is not known to have a 
DNA binding domain we assume that in this case TIP60β acts as a 
co-activator for one (or several) of the transcription factors that are recruited 
to the Herpes Simplex virus thymidine kinase promoter in the reporter 
plasmid. There are numerous examples for TIP60 acting as a co-activator 
(see above and (Baek et al., 2002; Brady et al., 1999; Halkidou et al., 2003)). 
 
The co-repressors SMRT, mSin3A/B and N-CoR recruit histone deacetylases 
(HDAC). Since ETV6 recruits these corepressors, inhibition of HDACs by 
TSA decreases ETV6-mediated transcriptional repression (Chakrabarti and 
Nucifora, 1999). When HDACs were blocked by TSA, the small TIP60β 
interacting domain of ETV6 (aa282-345) did not show any repressional 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
157 
activity. Indeed, it slightly activated the expression of the reporter gene (Fig 
4.20). However, upon co-expression of TIP60β with 
GAL4DBD-ETV6(282-345) under TSA conditions a clear co-repressional 
activity of TIP60β was observed. In other words, blocking endogenous 
HDACs unmasked the co-repressor acitivity of TIP60β. This observation also 
implies that the co-repression of TIP60β is not mediated through HDACs 
alone. In fact, as discussed below, an acetyltransferase (AT) dead mutant of 
TIP60β has reduced co-repressor activity implying an interesting new 
mechanism of TIP60-mediated transcriptional co-repression. These results 
suggest that the transcriptional repression activity of ETV6 might be 
mediated by both HATs and HDACs. 
 
To examine the functional consequences of the interaction between ETV6 
and TIP60β in a more physiological setting a second reporter gene assay 
was used. In this system ETV6 has to use its own DNA binding domain to 
bind to the reporter plasmid. This requirement also meant that only ETV6 as 
a whole could be used in order to be sure that the ets domain retained its 
three dimensional structure and was able to bind DNA. In this second system 
the expression of the luciferase reporter gene was controlled by a fragment 
of the rat stromelysin-1 promoter which contains an ets DNA binding 
sequences (EBS) and two ets potential binding sites (TBS) (Fenrick et al., 
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2000). In this system a clear co-repressor activity of TIP60β for ETV6 could 
be demonstrated (Fig. 4.21 and Fig. 4.22). It could also be shown that the 
acetyltransferase (AT) activity of the MYST domain of TIP60β is essential for 
this co-repression activity. An AT dead mutant of TIP60β (TIP60β-DRS) 
showed no co-repressor activity (Fig. 4.18). Since we could show that an AT 
dead mutant of TIP60β does not interact with ETV6 (Fig 4.4) it could be 
speculated that this failure to interact with ETV6 is the reason for the loss of 
TIP60β-mediated co-repression. The ETV6 serine to alanine point mutants at 
position 106 (S106A) and at position 332 (S332A) showed both an increased 
repressional activity when TIP60β was coexpressed (Fig. 4.22). The S106A 
mutant showed an overall stronger repression both with and without TIP60β 
expression. This observation could be due to the fact that the PIN1 regulatory 
site is not functioning anymore (see below) but that interaction with TIP60β 
and hence corepression is still possible. The stronger overall repression with 
the S106A mutant would then be due to the lack of the anti-repression activity 
of cellular PIN1. On the other hand the S257A mutant shows no significant 
change in repression when TIP60β is expressed. This could be due to lack of 
interaction of ETV6 with TIP60β because of the S257A mutant. These 
interesting observations imply that ETV6 function is controlled by several 
different posttranslational modifications at different sites of the molecule. 
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We as well others (Nordentoft and Jorgensen, 2003) have shown that the 
MYST domain zinc finger of TIP60 is essential for ETV6-TIP60 interaction. 
Nordentoft and Jorgensen showed that a point mutant, which destroys the 
MYST domain zinc finger of TIP60, abolished interaction with ETV6. We 
have previously shown that the MYST domain zinc finger of TIP60β alone is 
able to interact with the C-terminal portion of the central domain of ETV6 but 
is unable to interact with the complete central domain of ETV6 or full length 
ETV6 (Putnik, Ph.D. thesis, 2001; Putnik and Bohlander, 1999). In this thesis 
it could be demonstrated that TIP60β AT function is also required for 
interaction of TIP60β with full length ETV6. A TIP60β AT dead mutant failed 
to interact with full length ETV6 (Fig. 4.4) but was still able to interact with the 
same portions of ETV6 that also showed interaction with the zinc finger of 
TIP60β. Taken together, these results suggest that the interaction between 
ETV6 and TIP60β might involve two steps: 1) acetylation of ETV6; this 
acetylation would change the 3D conformation of ETV6 so that the domains 
that are recognized by the TIP60β zinc finger become exposed; 2) stable 
binding of ETV6 by the TIP60β zinc finger. 
 
Our results show that TIP60β is an important co-factor, which can modulate 
the transcriptional activity of ETV6. Since TIP60 itself is up-regulated after 
UV damage (Legube et al., 2002) and has been shown to be involved in the 
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p53 response (Berns et al., 2004). ETV6 might also be important in these 
pathways. 
 
5.3  PIN1 and the ETV6-PIN1 interaction 
 
Phosphorylation of proteins at serine or threonine residues which are 
followed by a proline is found in the regulation of many cellular functions such 
as cell cycle control, transcriptional regulation, differentiation and proliferation.  
ETV6 has been shown to be a nuclear phosphor protein (Poirel et al., 1997). 
The phosphorylation sites of ETV6 were mapped to serine 22 and serine 257 
(Arai et al., 2002). While serine 22 of ETV6 is constitutively phosphorylated, 
serine 257 was shown to be inducibly phosphorylated by the p38 MAPK 
(mitogen activated protein kinase). 
 
PIN1, which has been mentioned to interact with ETV6 by us (Putnik Ph.D. 
thesis) and others (Nordentoft and Jorgensen, 2003), is a peptidyl prolyl cis 
trans isomerase. PIN1 binds substrate proteins at phosphorylated serine or 
threoine residues followed by a proline with its WW domain. PIN1 then 
induces a cis – trans isomerization reaction of the peptidyl prolyl bond 
thereby changing the conformation of the substrate protein. It could be 
shown that the isolated WW domain of PIN1 exhibits the same binding 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
161 
properties towards the phosphorylated target proteins as full length PIN1 (Lu, 
et al., 2002). In contrast, the PPIase (peptidyl prolyl isomerase) domain of 
PIN1 had only low or no affinity to the substrate (Verdecia, et al., 2000).  
 
We were also able to observe this lower affinity of the PPIase domain of PIN1 
for ETV6. PIN1 full length as well as the isolated WW and PPIase domains 
showed the same interaction pattern with different ETV6 deletion mutants. 
The interactions of the PPIase domains with the ETV6 deletion mutants were 
slightly weaker. Interaction of PIN1 was observed with full length ETV6, the 
first 126 amino acids of ETV6, which include the pointed domain, and the 
C-terminal half of the central domain. Interestingly, there was no interaction 
between PIN1, the WW domain or the PPIase domain and the central 
domain of ETV6. The fact that PIN1 and its two domains interacted again 
with the C-terminal half of the central domain could be explained by steric 
hindrance or blockage of the PIN1 interaction interface in the C-terminal 
portion of the central domain by the N-terminal portion of the central domain. 
This situation is reminiscent of the interaction pattern observed between 
ETV6 and TIP60β. The inducibly phosphorylated serine 257 – Pro could be 
the target of PIN1 interaction in the C-terminal half of the central domain. 
Putnik could show that the strongest interaction between ETV6 and PIN1 
occurs if aa 1-126 (including the pointed domain) of ETV6 are used in the 
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mammalian two hybrid system (Putnick, Ph.D. thesis, 2001). Similar results 
were obtained in this work with the yeast two hybrid system (Fig. 4.5). Since 
it could also be shown that the first 59 amino acids of ETV6 (which contain 
the reported Serine 22 phosphorylation site) slightly interact with PIN1 (Fig. 
4.5), the interaction of PIN1 and the N-terminus of ETV6 (aa 1-126) might 
occur at the Ser106-Pro or the Ser22-Pro bond (Fig. 5.2). So three ETV6 
serine to alanine mutants at position106, Ser257 and Ser332 were 
constructed and tested in stromelysine-1 promoter-based reporter gene 
system (Fig. 4.14, Fig. 4.22 and Fig. 4.26). 
 
 
 
Fig. 5.2  Four potential PIN1 binding sites in ETV6 
 
The subcellular localization studies that we performed with a PIN1-YFP 
protein showed that PIN1 can be found in the cytoplasm and the nucleus with 
more staining in the nucleus. The bright green spots of PIN1-YFP were 
always prominently observed in the nucleus. This distribution could be 
caused by the overexpresseion of PIN1-YFP as well by its interacting with 
one or several of its different substrate proteins. The co-localization 
experiments of ETV6 (CFP-ETV6) and PIN1-YFP showed that both proteins 
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exhibit a similar staining pattern in the nucleus suggesting physical 
interaction of PIN1 and ETV6 (Fig 4.12). In some nuclei a striking dot like 
pattern of PIN1-YFP was observed. The same pattern could be seen in these 
nuclei in the distribution of CFP-ETV6. At the present time we are not sure 
whether this dot like pattern of PIN1-YFP represents an over-expression 
artefact or whether it has some physiological relevance. This suggests that 
PIN1 modulates the transcriptional function of ETV6 in the nucleus. This is in 
line with the observation that PIN1 can inhibit the binding of beta-catenin to 
APC and thereby lead to an increased localization of beta-catenin in the 
nucleus (Ryo, Nakamura et al., 2001). 
 
On a functional level the interaction of ETV6 and PIN1 had quite profound 
consequences for the well-known function of ETV6 as a transcriptional 
repressor. When PIN1 was co-transfected in the GAL4-UAS HSV thymidine 
kinase based reporter system the repressional activity of ETV6 was greatly 
inhibited (Fig 4.23). When PIN1 was co-expressed with ETV6 in the 
stromelysin-1 promoter based reporter system, ETV6 was turned from a 
repressor of transcription to a clear activator of transcription (Fig. 4.25). This 
is a very interesting observation since it implies that ETV6 might function as 
an activator of transcription under the appropriate cellular conditions and that 
PIN1 is critically involved in regulating the function of ETV6 (Zhang C.D. et al., 
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2004). When the three ETV6 serine to alanine point mutants were tested with 
PIN1 in the reporter gene assays, the repressional activity of the mutants 
ETV6(S257A) and ETV6(S332A) was still relieved. However, the 
transcriptional repression of the ETV6(S106A) mutant could not be relieved 
by PIN1 coexpression (Fig. 4.26). This indicates that phosphorylation at 
serine 106 is essential for the effect that PIN1 has on ETV6 function. If serine 
106 cannot be phosphorylated anymore, PIN1 is probably unable to 
isomerize Ser106-Pro107 bond. It can be hypothesized that PIN1 causes a 
conformational switch in the ETV6 protein through peptidyl-prolyl 
isomerization at Ser106 – Pro bond which converts ETV6 from a 
transcriptional repressor to a transcriptional activator. Since it is known that 
PIN1 interacts with many other proteins, it can be assumed that these 
proteins are regulated in a similar fashion by PIN1 (see reviews (Lu et al., 
2002; Lu, 2004; Shaw, 2002; Zhou et al., 1999)). 
 
Zhang C.D. Ph.D. thesis Munich 2004  
 
165 
 
 
A. 
Lu K.P. et al., 2002
B. 
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Fig. 5.3  Hypothetical model showing the effect of PIN1 peptidyl prolyl isomerization on 
the conformation of ETV6. A) Effect of PIN1 cis to trans isomerization on an isolated 
Ser-Pro bond. B. Diagram showing hypothetical effect of PIN1 action on the conformation 
of ETV6. The cis to trans isomerization of ETV6, which has to be preceded by serine 
phosphorylation, completely changes the conformation of the ETV6 protein. In this 
example the serine-proline bond at position 106 of ETV6 is affected by isomerization. 
 
Lu K.P. showed in 1996 that the depletion of PIN1 in HeLa cells induced 
mitotic arrest. Overexpression of PIN1 in Hela cells caused cells to arrest in 
G2 phase (Lu et al., 1996). In our experiments, PIN1 caused an increase in 
the proportion of S/G2/M phase cells in 293T cells. This observation is 
compatible with an arrest of the cells in S, G2 or M phase (Fig. 4.31). This 
effect of PIN1 expression was also visible when ETV6 was coexpressed. 
Although accumulation in S/G2/M phase was slightly less in these 
coexpression experiments (Fig. 4.33).  
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Summary 
 
The ETV6 gene is involved in many chromosomal translocations forming 
different fusion genes in both myeloid and lymphoid leukemias as well as in 
some solid tumors. ETV6 is a member of the ets family of transcription 
factors and has been shown to be a transcriptional repressor. There is also 
evidence that ETV6 is a tumor suppressor gene in certain leukemias. ETV6 
interacts with TIP60β and PIN1. TIP60 (HIV-1 Tat interacting protein, 60 kDa), 
a member of the MYST family of histone acetyltransferases, is a 
transcriptional co-activator or co-repressor depending on the interacting 
transcription factor. PIN1, an important peptidyl-prolyl cis/trans isomerase, is 
the only known enzyme to specifically isomerize phosphorylated serine or 
threonine - proline bonds. This isomerization reaction changes the 
conformation of the protein substrate and is a central signaling mechanism 
controlling normal cell proliferation and malignant transformation. In this work 
the interactions between ETV6 and TIP60β and between ETV6 and PIN1 
were analyzed in detail.  
 
Using the yeast two hybrid system the TIP60β interacting domain of ETV6 
was mapped to the C terminal half of the central domain of ETV6. The 
interaction between full length ETV6 and TIP60β was shown to be dependent 
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on an intact acetyltransferase activity (HAT) of TIP60β. Interestingly, the HAT 
deficient TIP60β mutant is still able to interact with the C terminal half of the 
ETV6 central domain. These results imply a complicated mechanism of 
ETV6-TIP60β interaction which might involve acetylation of ETV6 by TIP60β 
and a subsequent conformational change of ETV6. In transient 
co-transfection experiments using fluorescently tagged proteins ETV6 and 
TIP60β were co-localized in the nucleus. Reporter gene assays demonstrated 
that TIP60β is a corepressor of ETV6. This co-repressor activity of TIP60β 
was especially noticable when a reporter plasmid based on the 
ETV6-responsive stromelysin-1 promoter was used. TIP60β corepressor 
activity was dependent on an intact TIP60 acetyl- transferase domain. TIP60β 
did not exhibit corepessor activity for a serine to alanine mutant at position 
257 of ETV6. This result could be caused by a lack of interaction between 
ETV6(S257A) and TIP60β which might be due to a requirement for a 
phosphorylation / isomerization dependent conformational change of ETV6 in 
this region for TIP60β interaction. The expression of GFP-ETV6 had no 
discernible effect on the proportion of cells in the different phases of the cell 
cycle as compared to the expression of GFP or YFP. The expression of a 
TIP60β-YFP construct led to a marked reduction of the proportion of cells in 
the S/G2/M phase of the cell cycle. Coexpression of both GFP-ETV6 and 
TIP60β-YFP restored the normal distribution of cycling cells. 
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Similar studies were performed to analyze the interaction between ETV6 and 
PIN1. The PIN1 interaction domain of ETV6 was mapped to the pointed 
domain and to the C-terminal half of the central region of ETV6 in the yeast 
two hybrid system. In both regions, PIN1 consensus binding sites containing a 
serine/threoine – proline sequence are present. It could be shown that both 
the WW domain and the PPIase domain of PIN1 participate in the interaction. 
Co-localization of ETV6 and PIN1 was seen in the nucleus of transiently 
transfected cells. On a functional level, co-expression of PIN1 with ETV6 
markedly reduced the repressor activity of ETV6 when ETV6 was fused to a 
heterologous DNA binding domain (GAL4DBD). When the stromelysin-1 
promoter based reporter gene system was used, co-expression of PIN1 not 
only relieved ETV6 mediated repression but actually turned ETV6 from a 
transcriptional repressor to a transcriptional activator. A serine to alanine 
mutant at position 106 of ETV6 was completely unresponsive to PIN1 
coexpression which indicates that S106 of ETV6 is the main site of PIN1 
interaction. These findings show that ETV6 activity can be regulated in very 
decisive ways by interaction with PIN1. It could be that this regulation of ETV6 
through PIN1 is a result of ETV6 peptidyl-prolyl cis-trans isomerization and 
hence a conformational change of ETV6. Expression of YFP-PIN1 led to a 
slight increase in the proportion of cells in the S/G2/M phase. Like for TIP60β, 
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coexpression of GFP-ETV6 led to a restoration of the distribution of cycling 
cells. 
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Zusammenfassung 
 
Das ETV6-Gen ist an vielen chromosomalen Translokationen beteiligt und 
bildet viele verschiedene Fusionsgene. ETV6-Fusionsgene findet man 
sowohl bei myeloischen und lymphatischen Leukämien als auch bei 
gewissen soliden Tumoren.  ETV6 ist ein Mitglied der ets Familie von 
Transkriptionsfaktoren. Es gibt Hinweise darauf, daß ETV6 auch ein 
Tumorsuppressorgen bei Leukämien ist.  
 
ETV6 interagiert mit TIP60 und PIN1. TIP60 (HIV-1 Tat interacting protein, 60 
kDa), eine MYST–Domänen Histonacetyltransferase, ist ein transkriptioneller 
Ko-Aktivator oder Ko-Repressor je nachdem mit welchem 
Transkriptionsfaktor es interagiert. PIN1, eine wichtige peptidyl-prolyl cis 
trans Isomerase, ist das einzige bekannte Enzym, das spezifisch 
phosphorylierte Serin/Threonin–Prolin Peptidbindungen isomerisiert. Diese 
Isomerisierungsreaktion verändert die Konformation des Proteinsubstrats 
und ist ein zentraler Signaltransduktionsmechanismus der die normale 
Zellproliferation und die maligne Transformation kontrolliert. 
 
In dieser Arbeit wurde die Interaktion zwischen ETV6 und TIP60 und 
zwischen ETV6 und PIN1 im Detail analysiert. 
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Im Yeast Two Hybrid System konnte die TIP60-Interaktionsdomäne von 
ETV6 auf die C-terminale Hälfte der zentralen Region von ETV6 kartiert 
werden. Es konnte gezeigt werden, daß für die Interaktion zwischen dem 
vollständigen ETV6-Protein und TIP60 die Acetyltransferasefunktion (HAT) 
von TIP60 notwendig war. Interassanterweise, ist die HAT defiziente 
TIP60-Mutante noch in der Lage mit der C terminalen Hälfte der zentralen 
Region von ETV6 zu interagieren. Diese Ergebnisse legen nahe, daß der 
Interaktion zwischen ETV6 und TIP60 ein komplizierter Mechanismus 
zugrunde liegt, der möglicherweise acetylierungsabhängige 
Konformationsänderungen von ETV6 voraussetzt. In transienten 
Kotransfektionsexperimenten mit mit fluoreszierenden  Proteinen 
markiertem ETV6 und TIP60 konnte eine Kolokalisation der beiden Proteine 
im Zellkern beobachtet werden.  In Reportergenassays konnte gezeigt 
werden, daß TIP60 ein transkriptioneller Korepressor für ETV6 ist. Diese 
Korepressoreigenschaft von TIP60 für ETV6 wurde besonders in 
Reportergenassays sichtbar, die auf dem ETV6–responsiven Stromelysin-1 
Promotor basierten. Die TIP60-Korepressorfunktion war auf eine intakte 
HAT-Domäne von TIP60 angewiesen. TIP60 wies keine  
Korepressoraktivität für eine Punktmutante von ETV6, die an Position 257 
ein Alanin anstatt eines Serins hatte, auf. Dies könnte auf eine fehlende 
Interaktion zwischen ETV6(S257A) und TIP60 zurückzuführen sein. 
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Möglicherweise ist die TIP60-ETV6 Interaktion auf eine Phosphorylierung / 
Isomerisierungs abhängige Konformationsänderung von ETV6 in diesem 
Bereich angewiesen. Die Expression von CFP-ETV6 hatte keinen 
signifikanten Einfluß auf die Zellzyklusregulation im Vergleich zur Expression 
von CFP oder YFP alleine. Die Expression von TIP60-YFP führte zu einer 
merklichen Abnahme des Anteils der Zellen, die sich in der S/G2M Phase 
befanden. Die Koexpression von CFP-ETV6 und TIP60-YFP führte wieder zu 
einer normalen Verteilung der Zellen in den Phasen des Zellzyklus. 
 
Die Interaktion von ETV6 mit PIN1 wurde mit ähnlichen Experimenten 
untersucht. Im Yeast Two Hybrid System wurde die PIN1 Interaktionsdomäne 
von ETV6 auf die pointed Domäne und auf die C-terminale Hälfte der 
zentralen Region von ETV6 kartiert. In beiden Regionen sind PIN1 
Konsensus-Bindungsstellen vorhanden, die eine 
Serin/Threonin–Prolin–Peptidbindung enthalten. ETV6 und PIN1 konnten im 
Zellkern von transient transfizierten Zellen kolokalisiert werden. Funktionell 
konnte gezeigt werden, daß die Ko-Expression von PIN1 mit ETV6, die 
transkriptionelle Repressorfunktion von ETV6, wenn ETV6 als Fusion mit 
einer heterologen DNA Bindungsdomäne exprimiert wurde (GAL4DBD), 
deutlich reduzierte. In einem Reportergenassay, der auf dem 
ETV6-responsiven Stromelysin-1 Promoter basiert, verwandelte sich ETV6 
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durch Ko-Expression von PIN1 von einem Repressor zu einem Aktivator der 
Transkription. Diese Ergebnisse zeigen, daß ETV6 in seiner Funktion in ganz 
entscheidender Weise durch die Interaktion mit PIN1 reguliert wird. Es 
könnte sein, daß die PIN1-bedingte Regulation von ETV6 ein Resultat einer 
peptidyl-cis-trans Isomerisierungsreaktion an ETV6 ist, und somit durch eine 
Änderung der Konformation von ETV6 bedingt ist. Die Expression von 
YFP-PIN1 führte zu einer geringfügigen Zunahme der Zellen, die sich in der 
S/G2/M Phase des Zellzyklus befanden. Wie bei TIP60, führte die 
Koexpression von CFP-ETV6 zu einer Normalisierung der Zellen in den 
Phasen des Zellzyklus. 
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Abbreviations Used 
 
α  anti/alpha 
aa  amino acid 
Ab  antibody 
ALL  acute lymphoblastic leukemia  
AP  alkaline phosphatase 
ATP  adenosine triphosphate 
BCR  B cell receptor 
bp  base pair 
BSA  bovine serum albumin 
cDNA  complementary DNA 
CML   chronic myeloid leukemia  
CMV  cytomegalovirus 
Coom.  coomassie 
ddH2O  doubly distilled water 
DAPI  4´,6-diamidino-2-phenylindole 
DMEM  Dulbecco’s Modified Eagle Medium  
DMF  dimethylformamide  
DMSO  dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
dNTP  deoxynucleotide triphosphate 
DTT  dithiothreitol 
EB  ethidium bromide 
EDTA  ethylenediaminetetraacetic acid 
EGF  epidermal growth factor 
ER  endoplasmic reticulum 
ets  erythroblast transformation specific 
ETV6  ets translocation variant 6 
FCS  fetal calf serum  
GFP  green fluorescent protein 
GH  growth hormone 
GST  glutathione-S-transferase 
h  human 
HAT      histone acetyltransferases 
HDAC histone deacetylase enzymes  
HLH  helix-loop-helix  
hr  hour 
HRP  horseradish peroxidase 
Ig  Immunoglobulin 
IPTG  isopropyl-1-thio-β-D galactopyranoside 
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IRES  internal ribosomal entry site 
ITAM  immunoreceptor tyrosine-based activation motif 
kb  kilobase 
kDa  kilo dalton 
LB  Luria-Bertani medium 
2-ME  2-mercapto ethanol 
mAb  monoclonal antibody 
MAPK  mitogen activated protein kinase 
MCS  multiple cloning site 
MDS  myelodysplastic syndrome 
MOZ  monocytic leukemia zinc finger protein 
mRNA  messenger RNA 
MW  molecular weight 
NIMA1  never in mitosis A 
O.D.  optical density 
ORF  open reading frame 
PAGE polyacrylamide gel electrophoresis 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PDGF  platelet-derived growth factor 
PDGFRβ  platelet derived growth factor receptor β 
PEG  polyethylene glycol 
PI  propidium iodide 
PIN1  protein interaction with NIMA1 
PMSF  phenylmethylsulfonyl fluoride 
PoV  sodium pervanadate 
RNA  ribonucleic acid 
RT  room temperature 
SAM  sterile alpha motif 
SDS sodium dodecyl sulphate 
SEAP  secreted alkaline phosphatase 
sec  second 
SIRP  signal regulating protein 
SREs  serum response elements 
STAT  signal tranducer and activator of transcription 
TAE  tris acetate buffer 
TBS  tris buffered saline 
TCR  T-cell receptor 
TF   transcription factor  
TIP60β  human HIV tat interaction protein, Mw 60 KDa 
Tm  melting temperature 
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TNFα tumour necrosis factor alpha 
Tris-Cl  tris hydrochloride 
U  unit of enzymatic activity 
UBC9  ubiquitin-conjugating enzyme 9 
UV  ultraviolet 
v/v  volume-per-volume 
X-gal  5-Bromo-4-chloro-3-indoyl-β-D-galactopyranoside  
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